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Abstract
The lymphatic system plays important roles in tissue fluid balance, protein transport, and the
immune system, and has great potential for the delivery of certain drugs. Despite its importance,
our quantitative understanding of interstitial-lymphatic transport is limited. The first goal of this
work was to examine lymphatic function as an integral component of interstitial mechanics. A
theoretical description of this mechanical equilibrium was developed in parallel with a novel
experimental model. Tissue was modeled as a poroelastic continuum to describe the fluid
pressure distribution following an interstitial injection, predicting that spatial gradients would be
governed by the ratio of lymphatic to tissue resistances and temporal gradients governed
additionally by elasticity. The mouse tail was a unique experimental model for examining both
of these theoretical frameworks because of its geometry and anatomical features. Pressure
measurements using micropipettes showed remarkable consistency with the theoretical
assumptions and gave unique in vivo estimates of the effective parameter values (for tail skin,
hydraulic conductivity was 1.5 x 10-6 cm2 sec' * mm Hg', lymphatic conductance was 4 x 10.5
sec' . mm Hg' 1, and the bulk elastic modulus was 110 20 mm Hg). The second part of the
thesis built on this model of tissue fluid balance to describe convective transport of
macromolecules. 1-D concentration gradients in the tail could be observed using fluorescence
microscopy. These gradients were described in terms of a dispersivity and excluded volume
fraction as well as fluid convection. The model could characterize differences in transport
profiles of various molecules (differing in size, shape, and charge) and constituted an extremely
useful model for in vivo studies of convective transport. Finally, the model was applied to
studies in gene expression of the lymphatic system and to investigate the effects of edema,
tissue grafting, and mechanical forces on overall lymphatic function. This is the first in vivo
model of interstitial-lymphatic transport which accounts for the dynamics of the interstitium and
allows for simple and accurate in situ measurements of tissue elasticity, hydraulic conductivity,
and molecular transport parameters. Furthermore, it yields estimates for an effective or overall
conductance of the lymphatics which is important for examining pathological changes in
interstitial-lymphatic fluid.
Thesis supervisors: Rakesh K. Jain
Professor, Harvard Medical School
Linda G. Griffith
Associate Professor, Department of Chemical Engineering
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Chapter 1
Introduction
The lymphatics comprise a one-way transport system which is parallel to that of the
blood circulation. Its main function is to drain fluid and proteins from the interstitial space
and return them to the blood circulation. Lymph forms as fluid and molecules are driven
from the interstitium into the lymphatic capillaries (also called initial lymphatics) by
hydrostatic and osmotic pressure differences, and imbalance in the interstitial-lymphatic
complex can result in edema. Proteins and other macromolecules depend on the lymphatics
for interstitial clearance and systemic transport. Furthermore, any molecules or particles
traveling in the lymphatics pass through lymph nodes - reservoirs in which material can be
filtered and examined by white blood cells - yielding important immunological
consequences. Despite its importance, our physical understanding of lymph formation is
inadequate for application. For example, edema remains an untreatable condition, and the
clinical potentials of lymphatic drug delivery and targeting are largely unexplored. While
numerous aspects of blood flow have been studied extensively, tools for studying
lymphatic function are lacking and lymphatic transport remains largely ignored by the
bioengineering community.
A comprehensive and quantitative model is necessary to gain a better understanding
of interstitial fluid balance and the role of the lymphatics in maintaining this fluid balance.
Such a model would also be required to exploit the increasing potential of lymphatic drug
delivery (Charman et al 1992). Furthermore, the recent discovery of the first growth factor
for lymphatic endothelium (Jeltsch et al 1997) has ignited interest in lymphatic cell biology;
its relevance in lymphatic (tumor) metastasis and edema also motivates a quantitative
functional model.
The work presented in this thesis outlines (1) the development of the mouse tail as
an experimental model for quantitative investigations into interstitial-lymphatic transport,
(2) the parallel development of a theoretical framework to describe fluid and solute
transport in this experimental model, and (3) some applications of the model to relevant
physiological issues. This is diagrammed in Figure 1-1. After a brief summary of the
background in Chapter 2, Chapter 3 describes the experimental model and the techniques
which were used for various measurements. Chapter 4 examines flow within the lymphatic
capillary network both on an averaged scale using residence time distribution theory as well
as locally using photobleaching methods. Chapter 5 investigates interstitial-lymphatic
mechanics by evaluating the mechanical response to a perturbation in tissue stress.
Interstitial solute transport is examined in Chapter 6, building on the mechanical framework
of Chapter 5 along with convective-dispersive theory. Finally, Chapter 7 describes the
application of the model along with surgical techniques and the tools of molecular biology
to evaluate changes in tissue fluid balance during lymphedema, tissue grafting, wound
healing, and lymphatic hyperplasia.
In all these studies, tissue is treated as a "packed bed" for analyses of fluid and
macromolecular transport. Modeled as a porous fluid-filled elastic medium, pressure
gradients can be measured to estimate fluid transport parameters in situ. Modeled as a
chromatography column, resistances to interstitial and lymphatic transport of
macromolecules can be estimated. Coupled with the potentials of surgical and genetic
alterations and measurements of gene expression, this constitutes a very powerful tool for
simultaneous studies of nearly every aspect of interstitial-lymphatic transport.
Lymphedema,
tissue grafting,
and associated
changes in tissue
parameters
Kb
4-
n vivo estimates of
excluded volume
fraction and lymphatic
reflection coefficient
Figure 1-1. Flow diagram of thesis outline.
Chapter 2
Background
2.1 The lymphatic system
2.1.1 Lymph formation
The lymphatics comprise a one-way transport system for fluid and proteins which
are collected from the interstitial space and returned to the blood circulation. The terms
"lymphatic capillaries" or "initial lymphatics" are used to describe the blind-ended
structures in which lymph initially forms. The simplified relation between blood,
interstitium, and lymph is depicted in Figure 2-1. As blood travels from the branching
arteries down to the smallest capillaries, plasma and proteins are forced out into the
interstitial space or interstitium (the tissue space not occupied by cells). Most of this fluid
gets reabsorbed into the post-capillary venules, but a small fraction remains in the tissue
due to osmotic forces resulting from the leakage of proteins. This excess is drained by the
initial lymphatics, which are more permeable to macromolecules than the interstitium and
thus serve a crucial role in maintaining osmotic and hydrostatic pressures within the tissue
space. Finally, the cell entering the lymphatic in Figure 2-1 signifies the importance of the
lymphatic system for the transport (and residence) of white blood cells and sometimes
metastasizing cancer cells.
R to Blood
Initial lymphatic
9- 9
V
Figure 2-1. Cartoon depicting the blood-tissue-lymph interface. RBC = red blood cell;
WBC = white blood cell.
Lymph formation is presumably driven by hydrostatic pressure differences and
controlled by a permeability or conductance. Starling's Law is the equivalent of Darcy's
Law for fluid flux into or out of a vessel (J,) and has been used for over 100 years to
describe lymph formation:
s = L (AP - aAm) (2.1)
where L is the permeability, S/V is the surface-area-to-volume ratio, AP and Ar are the
local hydrostatic and osmotic pressure differences across the lymphatic capillary wall,
respectively, and a is the capillary osmotic reflection coefficient. For the lymphatics, A7r is
typically considered negligible compared to AP because lymphatic vessels have
overlapping junctions between endothelial cells and thus permeability to solute molecules is
high (Schmid-Sch6nbein 1990, Hammersen and Hammersen 1985, Castenholz 1984,
Leake and Burke 1966). While Starling's Law may hold true, it is not useful for evaluating
experimental data because (1) LP strongly depends on the state of stress of the tissue, and
(2) the high permeability of the lymphatic capillaries results in a very small driving force for
lymph formation (AP). Reddy et al (1975) proposed that the pressure within the initial
lymphatics (PL) mimicks that of the tissue (PT) according to the hoop stress, ,hoop, which
depends on various properties of the lymphatic vessel such as its elastic modulus and
unstressed radius:
P, = PT + - ahoop (2.2)
a
where h and a are the thickness and instantaneous radius of the vessel, respectively.
However, this is an oversimplified description: it does not not account for natural stress
oscillations or the oscillations in LP, and moreover, the initial lymphatics are not cylindrical
in their unstressed state. The fact that the initial lymphatic is an integral part of the
interstitium is ignored, which is a common mistake in mathematical descriptions of lymph
formation.
The interstitial-lymphatic interface is depicted in Figure 2-2. Since they have no
smooth muscle or basement membrane (Schmid-Schtnbein 1990) and are often found in a
collapsed or partially collapsed state, the lymphatic capillaries rely on sensitive connections
to the extracellular matrix (ECM) called anchoring filaments. These fibers strongly attach
the basal lamina to adjacent collagen fibers (Leak and Burke 1966, Leak 1970) which have
similar structure and composition to the elastin components of the ECM (Gerli et al 1991)
Responding to slight tissue stresses, they exert radial tension on the lymphatic endothelial
cells and pull the capillary towards a cylindrical shape to facilitate lymph formation. This
creates a slight vacuum into which fluid may be drained. Since most natural stresses within
the tissue are oscillatory, this mechanism is adequate for the relatively small volumetric rate
of lymph formation.
Figure 2-2. Drawing of the lymphatic capillary cross-section and its anchoring filaments
(not to scale). Courtesy of Arja Kaipainen.
Following lymph formation, lymph flows from the initial lymphatics or capillaries
to the collecting lymphatics, which have some smooth muscle and one-way valves to aid in
lymph propulsion. These valves are critical in lymph flow, since the lymphatic system does
not have a central pump as does the blood circulation. Furthermore, lymph flows at low
Reynolds numbers (Schmid-Schnbein 1990, Fung 1984) and therefore the valves prevent
retrograde flow. Most valves are bicuspid (Ohtani et al 1986, Fabian 1983, Gnepp 1976,
Lauweryns 1971, Takada 1971, Kampmeier 1928) to facilitate such slow flow. Details of
the collecting lymphatics and larger vessels are described in a recent review by Schmid-
Sch6nbein (1990).
2.1.2 Lymphatic uptake of molecules and particles
It is believed that size is the most important determinant of lymphatic uptake
(Bergqvist et al 1983) and lymph node retention (Charman et al 1992). Molecules which
are smaller than 10 nm are preferentially reabsorbed into the blood capillaries, but the
optimal size for lymphatic uptake is between 10 and -100 nm. Molecules or particles up to
1 pm may be taken into the lymphatics, but above 100 nm, a percentage of injected solute
will remain trapped in the interstitial spaces for longer periods of time and thus have lower
uptake efficiencies. For example, liposomes of 30-60 nm were found to have faster uptake
rates than those of 400 nm, but the smaller ones also showed higher level in the blood
circulation (Strand and Bergqvist 1989).
The composition of the molecule or particle is also important in determining uptake
and lymph node retention. Colloids and liposomes seem to improve uptake efficiency.
Colloidal carbon has been suggested for lymphatic drug delivery applications because of its
apparent benefit to lymphatic uptake. Anticancer drugs absorbed to colloid carbon particles
of 200 nm showed markedly increased lymph node levels than those obtained with
solutions of the same drugs (Hagiwara et al 1989, Hagiwara and Takahashi 1987,
Hagiwara et al 1985); furthermore, the activated carbon enhanced preferential adherence to
malignant cells and slowed release characteristics. Lipophilicity has also been associated
with uptake efficiency (Torchilin 1996, Hirano et al 1985, Tumer et al 1983, Jackson
1981). Depending on the size, charge, method of preparation, and composition, various
molecules such as monoclonal antibodies, peptide drugs, and anticancer agents may be
encapsulated into liposomes and optimally targeted to lymph nodes (Charman et al 1992,
Hirano et al 1985, Mangat and Patel 1985, Ohsawa et al 1985, Weinstein 1984, Ryman et
al 1978). Furthermore, the liposome can be coated (e.g. with polyethylene glycol) to
improve lymph node retention by avoiding white blood cell phagocytosis; such "stealth"
liposomes are well-characterized and can be designed for a number of specific purposes
(Torchilin 1996). Microspheres of various materials have also been shown to be effective
drug carriers which can be targeted to lymph nodes; for example, microspheres of L-lactic
acid oligomer are stable, nontoxic, biodegradable, andshow good release characteristics
(Yoshikawa et al 1989).
2.1.3 Lymphatic endothelium
There are many similarities between endothelium of blood vessels and that of
lymphatics. For example, the requirements and characteristics of cell growth are similar
(Yong and Jones, 1991) and lymphocyte binding to lymphatic endothelial cells is not
significantly different from binding to venous or arterial endothelial cells (Borron and
Hay 1994). With respect to morphogenetic properties, lymphatic endothelial cells
behave similarly to vascular endothelial cells in vitro. They both exhibit spontaneous
angiogenesis, and they both respond to bFGF and VEGF similarly (Pepper et al 1994),
express anti-thrombin 3 and von Willebrand factor on their surfaces, and actively
metabolize acetylated low density lipoprotein (Borron and Hay 1994).
The endothelia of the lymphatic capillaries differ from those of the blood in that
they have little or no basement membrane, overlapping cell junctions, and anchoring
filaments which adhere to the surrounding collagen fibers of the ECM. Therefore they
may be distinguishable by staining for the structural proteins of the basement
membrane, such as collagen IV and laminin (Barsky et al 1983). Furthermore,
histological distinctions include the use of 5'-nucleotidase (5'Nase), which is specific
for lymphatic endothelium, along with alkaline phosphatase (ALPase) or guanylate
cyclase (GC) for blood endothelium (Endo et al 1994, Yoshizawa et al 1994). Finally,
it has been shown that an fms-like tyrosine kinase receptor, Flt4 (also called vascular
endothelial growth factor receptor-3, or VEGFR-3), becomes restricted to the lymphatic
endothelium during development (Kaipainen et al 1995). Receptors of the tyrosine
kinase family are known to play important roles in the proliferation, migration, and
permeability of endothelial cells (Ullrich and Schlessinger 1990, Folkman and
Klagsbrun 1987). This particular receptor is activated by the lymphatic-specific
vascular endothelial growth factor VEGF-C (Jeltsch et al 1997). Therefore Flt4 can be
used to identify lymphatic endothelial cells.
2.1.4 Methods for the assessment of lymphatic function
Transport studies in lymphatic capillaries have been limited by the lack of an
appropriate quantitative in vivo model. Cannulation of small vessels is technically difficult
and highly invasive. Lymphatic function is usually characterized by the tissue clearance
rate, which describes the removal of labeled molecules or colloids in terms of amount per
unit time per unit tissue volume. This method is straightforward and provides a relative or
semi-quantitative measure of lymphatic function (Mortimer et al 1990, Hollander et al
1961). Lymph formation can be observed in skin and mesentery by injecting an optical
contrast agent such as mercury (Mandell et al 1993, McNeill 1989, Engeset and Tjitta
1960, Hudack and McMaster 1933) or fluorescently labeled macromolecules (Castenholz
1991, Bollinger et al 1981). This procedure is commonly termed microlymphangiography
and can provide a clinical diagnostic tool for the characterization of edema (Bollinger and
Fagrell 1990). Other methods for evaluating lymphatic function include measurements of
plasma-to-lymph clearance (Renkin and Wiig 1994, Mortimer et al 1990) and local
measurements of lymphatic capillary pressures (Ikomi et al 1997, Wen et al 1994, Bates et
al 1994, Zaugg-Vesti et al 1993, Zweifach and Prather 1975).
While these methods are useful both experimentally and clinically in understanding
lymphatic function and edema, they have limited use in identifying and exploring the
dynamics of lymph formation and the physiological variables which govern lymphatic
function. Specifically, they present a lumped or grossly macroscopic picture of the entire
interstitial-lymphatic system. For example, the local uptake of an injected solution is the net
result of both tissue and lymphatic transport processes whose initial equilibrium is
disturbed by the injection in undefined ways, and as such, a measurement of the overall
uptake rate alone cannot elucidate the mechanisms by which lymphatic uptake occurs.
2.2 The extracellular matrix
The composition and organization of the extracellular matrix (ECM) determines the
properties of a tissue such as its elasticity and strength. Collagen fibers give structural
stability and form the skeletal framework onto which tissue is composed. Elastin provides
elastic properties. Glycosaminoglycans (GAGs) are highly negatively charged
macromolecules which "glue" the other matrix proteins together and imbibe water. It makes
up a gel-like phase together with water and interstitial proteins. GAGs are commonly
correlated to interstitial fluid transport resistance (Jackson et al 1991, Levick 1987, Granger
1981) and a disruption of normal GAG composition is ascribed to arthritis in articular
cartilage (Mow 1984, Grodzinsky 1983) as well as loss of tissue elasticity associated with
lymphedema (Negrini et al 1996). The composition and structure of the interstitium has
been extensively reviewed by others (Jackson et al 1991, Levick 1987, Grodzinsky 1983,
Granger 1981, Hargens 1981).
In skin, the random organization of collagen fibers and high GAG content govern
its mechanical properties (Granger 1981, Markenscoff and Yannas 1979, Craik and McNeil
1965, Kenedi et al 1965). Skin typically contains approximately 20% collagen, 40% water,
and 0.3% GAG (Aukland and Reed 1993), two-thirds of which is hyaluronic acid or
hyaluronan (HA). HA is synthesized by fibroblasts (Prehm 1984) and has a molecular
weight of several million (Preston et al 1984) but is routinely broken down with mechanical
strain or age (Negrini et al 1996, Lebel et al 1989, Laurent and Granath 1983). Turnover of
HA is on the order of one day (Laurent et al 1991, Reed et al 1990), and removed by the
lymphatic system. Therefore HA is critical to tissue fluid balance and elasticity, and is of
major importance in edema.
2.3 Edema
Edema is a condition of tissue fluid imbalance often resulting from infection, trauma
(from burns or radiation), surgery, and tissue grafting and transplantation (Mortimer
1997). It can also be congenital as shown in Figure 2-3. Although edema affects millions
of people, it is virtually untreatable. Attempts at treatment have included drug therapy,
physical therapy, and surgical approaches; these have yielded little success, particularly in
the long term (Mortimer 1997, Campisi et al 1995, Baumeister et al 1990, Savage 1984,
Huang et al 1985).
The pathological basis of edema can be described by considering lymph formation
as a passive process which is intrinsically linked to interstitial fluid movement and
governed by mechanical forces. The first step in the development of edema is an offset in
the mechanical equilibrium. This can occur by a blockage of the lymph node, buildup of
osmotic forces within the interstitium, damage to the interstitial-lymphatic connections, or
change in the mechanical properties or composition of the ECM.
The lymph nodes can typically become blocked by infection, tumor metastasis, or
surgical removal. Post-mastectomy edema is a common ailment of breast cancer patients.
This essentially severs the lymphatic network in the limb or region which led to that node
with the systemic lymph flow. The initial lymphatics maintain their drainage capacity, but
become "backed up" when lymph cannot drain from the deeper collecting vessels. As a
result, there is no driving force for lymph formation and tissue swelling results.
A change in oncotic pressure can result from hyperpermeability of the blood
microcirculation. This has been treated with some success using drugs of the benzopyrone
family such as Coumarin (Casley-Smith et al 1993, Casley-Smith 1992). These drugs
stimulate proteolysis by macrophages and thus effectively reduce oncotic pressure within
the interstitium. However, sustained edema elicits ECM reorganization by fibroblasts,
leading to an overall decrease in tissue elasticity. This can also cause protein accumulation,
which exacerbates the problem (Negrini et al 1996, Casley-Smith and Gaffney 1981).
Thus, edema is a serious problem and its treatment has seen little progress. Surgical
techniques have mostly failed (Mortimer 1997, Campisi et al 1995, Baumeister et al 1990,
Savage 1984, Huang et al 1985) and the benzopyrone drugs are not approved for use in the
United States. This lack of progress is mostly due to deficiencies in adequate models and in
Figure 2-3. Congenital lymphedema of the leg.
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our understanding of interstitial-lymphatic mechanics and lymphatic cell biology. Because
of this, there is little basis for rational therapeutic approaches (Mortimer 1997).
2.4 Summary
The formation of lymph and the uptake of solute into the lymphatic system is not
well understood, particularly in relation to the interstitium. This is evidenced by (1) the lack
of treatment options for conditions like edema and diseases of the lymphatic system; (2) the
poor level of understanding of lymphatic cell biology and its relation to tissue fluid balance
on a macroscopic scale; (3) the fact that lymphatic drug delivery is not fully realized despite
its great potential; and most of all, (4) the lack of experimental and theoretical models which
can be used to study interstitial-lymphatic transport. As this thesis attempts to address these
issues, the literature is reviewed and discussed in relation to the experimental and
theoretical developments.
Chapter 3
Experimental Model and Methods
3.1 Introduction
The first step in this thesis work was to develop an experimental model which was
well-defined and could yield quantitative and reproducible measurements of interstitial-
lymphatic transport. This section describes the evolution of such a model, and introduces
its uses and applications which ensued. As will be shown in subsequent chapters, the
model surpassed expectation in its usefulness and diversity in elucidating function,
mechanics, and gene expression simultaneously and in situ.
3.1.1 Lymphangiography and microlymphangiography
As described in Chapter 2, the technique of lymphangiography allows lymphatic
vessels to be visualized by interstitial injections of an optical, radioactive, or fluorescent
contrast agent. Microlymphangiography refers to the specific staining of lymphatic
capillaries (or initial lymphatics) following an intradermal injection. This technique can
readily give some qualitative information about the state of tissue fluid balance. Consider
the following cases: (1) normal tissue, (2) tissue which has decreased elasticity, (3) tissue
in which the initial lymphatics are not functioning properly, and (4) tissue in which the
lymph nodes are blocked so that the collecting lymphatics are not draining properly.
In normal tissue, the injection of contrast agent creates a local, temporary
perturbation in tissue stress. Tension on the anchoring filaments opens up the initial
lymphatic vessels and facilitates local uptake of the contrast agent. In this way the initial
lymphatics are rendered visible to the extent in which drainage to the deeper collecting
vessels takes over.
For the second case, a decreased elasticity could be due to a number of reasons
including chronic edema or some other mechanisms of extracellular matrix (ECM)
degradation. With a "loose" or less structured ECM, local increases in tissue stress which
would normally facilitate drainage are now greatly reduced and therefore the driving force
for lymph formation is weak. Microlymphangiography would show slower network
staining and a greater interstitial deposit of contrast agent.
The third case of abnormally functioning lymphatics is often seen in
lymphangioma, where the endothelial cells of the initial lymphatics proliferate in an
exaggerated manner and lose their sensitivity to tissue stress or swelling. In such distended
vessels, small perturbations in tension do not appreciably "open up" the vessels to facilitate
filling. They simply adjust their shape rather than increase their cross-sectional area. For
this case, microlymphangiography would show little or no filling and only an interstitial
deposit.
Finally, the blockage of lymph nodes are common as a side effect of cancer
therapies such as radiation or surgery as well as a primary effect of lymph node tumors.
When the lymph nodes are blocked, local vessels can still collect fluid in the normal manner
but they cannot drain to deeper vessels which have nowhere to move fluid. In such a
situation, microlymphangiography often results in the staining of a much more extensive
superficial network (Bollinger and Fagrell, 1990). That is, since they cannot drain to the
collecting lymphatics, they continue to travel through the capillary network and stain a
much greater network portion than normal.
Therefore, with a simple observation of an interstitial injection, uptake efficiency
and drainage to deeper vessels can be qualitatively estimated by the area and pattern of
visible network. Fluorescence microlymphangiography is emerging as a clinical diagnostic
tool to characterize edema and speculate cause (Bollinger and Fagrell 1990).
3.1.2 Mouse tail skin model
Microlymphangiography as described by Bollinger has a limitation, however, of
quantification. First, a bolus injection is not perfectly reproducible, and the drainage to
deeper vessels limits the extent of visible network in tissues such as the foot or hand (limbs
are most commonly prone to edema). Therefore in order to develop this into a quantitative
technique, an appropriate animal model was needed along with some control and
reproducibility.
Dr. Anders Leu first discovered the lymphatic network of the mouse tail skin while
looking for such a model. The technique of fluorescence microlymphangiography was
adapted to the tail skin of the mouse to visualize the lymphatic capillary network there (Leu
et al 1994). The mouse tail exhibited a strikingly regular hexagonal network which,
following injection into the tip of the tail, filled in an approximately one-dimensional
manner as shown in Figure 3-1.
Figure 3-1. Microlymphangiography in the mouse tail. Top left: An injection of FITC-Dx
2M (0.0125 g/ml) at the tip of the tail fills the surrounding interstitial space according to the
amount injected, rate of injection, fluid conductivity of the tissue, and functioning of the
lymphatics. Bottom left: The capillaries become visible as the lymphatics drain and
transport the fluid away from the injection deposit. Top right: Downstream from the
injection, the network continues to appear in a dispersed manner according to the overall
propulsion speed in the lymphatic capillary network. Bottom right: After approximately 30-
60 min, the entire lymphatic network is visible for approximately two-thirds of the tail
length. Mesh diameter is approximately 400 microns.
Model features
The mouse tail model exhibited several features which made it conducive to
quantitative studies of interstitial-lymphatic transport phenomena. For example, an injection
at the tail tip allowed transport only in the proximal direction (i.e. toward the animal), first
within the tissue interstitium and then within the lymphatic network. This is a painless
procedure which requires anesthesia only to immobilize the animal for observation; it is
also relatively noninvasive and the animal can be observed repeatedly for several months.
Furthermore, a cross-section of the mouse tail, shown in Figure 3-2, demonstrates that the
tail is essentially an annulus of dermal and subcutaneous tissue (skin) surrounding a core of
bone and tendons . There are many other tissues seen in this cross-section, such as hair
follicles, sebaceous glands, and the epidermis, but injected fluid is not likely to flow
through these tissues since the dermis and subcutis have a much lower hydraulic
conductivity (Levick 1987). As such, interstitial transport of the material which is injected
intradermally occurs in a fairly homogeneous tissue and mostly in one direction. (This can
also be shown by a simple scaling analysis; see Section 5.3 where radial gradients in
pressure and stress are shown to be negligible compared to axial ones.)
Another favorable feature of tail skin lymphatics is shown in Figure 3-3. Using
mercury injections, Engeset first demonstrated the lymphatic pathways in the rat tail
(Engeset and Tjbtta, 1960). The superficial vessels (not visible here) drain to two deeper
vessels which lead to the ischial lymph nodes near the base of the tail. In this way, the
system is essentially contained and can become closed with the ligation or blockage of these
lymph nodes. This is used to create edema in the tail and is examined in Chapter 7. These
features, along with the variety of observation techniques which will be explored
throughout this thesis, render the model unique both for quantitative physiological studies
as well as theoretical modeling.
Figure 3-2 Cross section of a nude mouse tail used in these studies, approx. 10 mm from
the tip, stained with Toluidine Blue. Scale bar: 100 microns. B = bone, V = venule, L =
lymphatic capillary, A = arteriole, Ad = adipose tissue, H = hair follicle, M = skeletal
muscle bundle, E = epidermis. Courtesy of Mit Endo.
H
Figure 3-3. Roentgen-photograph of the lymphatic vessels of the rat tail. Because of the
low resolution of this technique, only the deeper vessels and draining lymph nodes can be
seen. Arrows indicate the ischial lymph nodes. Taken from Lymphatic pathways from the
tail in rats and mice (Engeset and Tjbtta, 1960).
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3.2 Experimental setup
3.2.1 Animals
All studies were carried out in female nude mice that weighed between 20-30 g.
Nude mice were used because their qualities of hairlessness and non-scaly skin were
ideally suited for in vivo fluorescence microscopy. All protocols were approved by the
Subcommittee on Research Animal Care of the Massachusetts General Hospital (protocols
#93-4147 and #96-4140). Anesthesia was s.c. injection of ketamine hydrochloride at 0.01
mg/g body weight (Ketalar, Parke-Davis, Morris Plains, NY) and xylazine at 0.001 mg/g
(Rompun, Haver Mobay Corporation, Shawnee, KS). Before any procedure, the tail was
gently washed with soap and water to remove particulates that might interfere with
fluorescence measurements and then wiped with an ethanol-soaked gauze pad. The mouse
was placed on a small plate (12x5") in the supine position and its tail immobilized from
underneath with double-stick tape to avoid imposing pressure on the skin. This plate was
placed above a heating pad (Model HP20, Pollenex, Chicago, IL). A rectal probe (Digi-
sense, Model 8528-10, Cole Parmer, Chicago, IL) was used to monitor body temperature,
which was maintained between 36 and 38 "C throughout all experiments.
3.2.2 Step increase in IFP
Fluorescent dye was administered to the mouse tail at constant pressure using the
following scheme, illustrated in Figure 3-4. A calibrated 3-foot long (3/4" diameter) glass
cylinder was connected to two feet of flexible tubing, which in turn was connected to PE-
20 tubing (i.d. = 0.38 mm, Intramedics, Parsippany, NJ) with a 3-way stopcock (Baxter,
Irving, CA). To the open end of this stopcock was attached a 60 ml syringe (Becton-
Dickinson, Franklin Lakes, NJ) which facilitated pressure adjustments and tube filling.
The narrow tubing ended with a 26 G 1/2" needle (Becton-Dickinson) for inserting into the
tip of the mouse tail with the stopcock closed. At the beginning of any experiment, the
stopcock was opened and a constant pressure injection thus administered at the tip of the
needle.
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Figure 3-4. Experimental setup for a step-wise, constant pressure infusion into the mouse
tail skin.
The glass cylinder was filled with water to the desired pressure (10 to 60 cm water)
and the tubing filled with the dye solution from the needle. Except for the experiments
described in Chapter 5, and unless otherwise stated, the dye was a 1% (w/v) solution of a
fluorescently tagged molecule or particle in 0.9% saline (Abbott Labs, North Chicago, IL).
These included dextran labeled with fluorescein isothiocyanate (FITC-Dx) of molecular
weight 2M, 400K, 70K, 40K, and 4K; dextran labeled with rhodamine-B isothiocyanate
(RITC-Dx) of molecular weights 4K and 73K (Sigma), FITC-labeled anionic dextran 4K
(Molecular Probes, Eugene, OR), FITC-BSA (Sigma), and fluorescent microspheres
(Molecular Probes) with various diameters ranging from 0.01-1.0 pm. Each appropriate
molecule or particle is specified in individual experimental descriptions in later chapters. A
small bubble, far upstream from the needle, permitted the injected volume to be monitored
over time (see Section 3.4).
For all experiments, the infusion needle was inserted intradermally (or
subcutaneously, since we did not make a distinction between these two tissue types at the
tail tip - see Figure 3-9), in a proximal direction parallel to the tail axis, approximately 2
mm into the tip of the tail. At the beginning of an experiment (t=0), the stopcock was
opened, creating a step change in pressure at the tip from physiological baseline IFP
(normally around 9 mm Hg) to the reservoir pressure and thereby injecting the fluorescent
solution into the tail. The total length of any experiment varied from 1 to 3 hours. The rate
of fluid introduced ranged from 0 to 0.2 tl/min into approximately 20 to 30 mm3 of tissue
in normal mice, or up to approximately 10 il/g/min. This flow rate was an order of
magnitude larger in edematous tails, which is addressed in Chapter 7. In all cases, the tail
circumference or diameter at the injection site remained constant throughout the experiment
as measured by a suture thread or caliper.
3.3 Intensity measurements
Fluorescent images of the tail skin interstitium and lymphatics were visualized with
an epifluorescence microscope (Zeiss, Germany). A 100-Watt mercury lamp (Osram,
Germany), using a stabilized power supply (Oriel, Stratford, CT), passes first through a
heat filter (Zeiss Califlex) before illuminating the mouse tail. Images were collected with a
CCD video camera (Hamamatsu Photonics model XC-77, Hamamatsu, Japan) processed
through an image processing board. In all studies with one fluorescent probe, a fluorescein
label was used and a fluorescein (485 nm) excitation filter was used (Zeiss). For the
particle size study of Chapter 4 and the experiments in Chapter 6, two fluorescence
channels (Omega Optical, Brattleboro, VT) were used. The first had a fluorescein excitation
filter, a 505 nm dichroic mirror, and a 535 nm bandpass emission filter to measure
fluorescence from the fluorescein-labeled molecules or green fluorescent microspheres. The
second had a 540 nm excitation filter, a 565 nm dichroic mirror, and a 590 nm emission
filter to measure fluorescence from the rhodamine-labeled molecules or red microspheres.
With these two filter sets, no signal overlap was detected between the two fluorophores.
Flow was categorized in two regions of the tail. The injection site refers to the
characteristic length of the injection; that is, where IFP decayed from the injection pressure
to near the baseline pressure (a few millimeters in most cases). This was also where most
of the interstitial fluorescence was seen, assuming sufficient time for the injection region to
become saturated with the injectate. Within this region, gradients in intensity were recorded
for the interstitial transport studies in Chapters 6-7, and IFP was measured in Chapter 5.
Downstream from the injection site, the lymphatic capillaries were visible as shown in
Figure 3-1. This is referred to as the downstream region and it is the focus of Chapter 4.
To provide markers for viewing different sections of the tail by intravital
microscopy, short pieces of suture were placed loosely across the tail at various distances
from where the needle tip would be positioned. For the RTD experiments of Chapter 4,
where the downstream region was of interest, these sutures were placed 9, 15, 21, and 27
mm from the needle tip. For the transport studies of Chapters 6-7, where interstitial
transport was measured in the injection region, two sutures were placed 4 and 10 mm from
the needle tip.
The first data point was taken just before beginning the infusion for a background
intensity. At each time point, the first window was illuminated and an image acquired either
into the image processing board for on-line analysis (Chapters 4 and 7) or saved directly as
pixel data for later analysis (Chapter 6). Different cameras, image processing boards and
software were used for different studies. A Hamamatsu charge-coupled device (CCD)
camera (Hamamatsu, Japan) was used for all image acquisition except the studies described
in Chapter 6. For these macromolecular transport studies, greater resolution was desired
and so a high-performance camera system (SenSys, Photometrics, Tuscon, AZ) with a
CCD chip (Kodak KAF0400), was used to acquire images over longer periods of time
(which integrated the images and improved signal-to-noise ratio). Images were analyzed
either on-line or off-line. For the RTD studies of Chapter 4, a DT-Iris processing board
was used (Data Translation, Marlboro, MA) with a PC interface (IBM) to acquire intensity
histograms and extract average values at each timepoint. For the studies in Chapter 6,
however, each image was acquired as one file and then analyzed later by NIH Image
software (NIH, Bethesda, MD). Time points were taken every 5-10 minutes. More details
will be given in each section.
From the intensity histograms of each subregion, mean intensities were recorded so
that each subregion then had its own intensity - time curve. The intensity was normalized as
O= - n (3.1)
max - Imin
where I is the intensity, I~, is the initial background intensity, and Imx is the steady-state
intensity. This normalized intensity was assumed to be equivalent to the normalized
concentration profile in the tissue, although it was not possible to calibrate tissue
concentration with intensity. The intensities of all injected solutions were small enough to
yield linear concentration-intensity relationships in flat glass capillary tubes (1 mm depth)
for concentrations of the injectate, and intensity within the tissue was always less than that
of the injectate (as measured in the 1 mm flat capillary tube).
3.4 Flow measurements
To measure the infusion flow rate, a bubble is introduced into the tubing and its
position monitored. Calibrations were made using a syringe pump (Harvard Apparatus
Model 55-2226, South Natick, MA) in a range of 0.05 to 5.0 jl/min and are shown in
Figure 3-5. Using only saline in the line, inaccuracies in this flow meter were revealed;
bubble velocity often lagged behind the imposed velocity in the tubing. Therefore, to
maintain surface tension and prevent bubble slippage so that it moved reliably with the fluid
velocity, a solution containing 4% (w/v) bovine serum albumin (Sigma) - with 0.5% Evans
Blue (Sigma) to aid in visualization - was added to the system in the following way. First,
the blue albumin solution was drawn into the PE-20 tubing. Then a small bubble,
approximately 1 mm long, was introduced, followed by approximately 1 ml albumin
solution. Finally, the fluorescent solution was drawn to 2-3 times the required length; in
this way the mixing that occurred at the albumin-dextran interface would not affect the
infusate.
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Figure 3-5. Imposed fluid velocity vs. measured bubble velocity in the bubble flow meter.
The open squares show the original system (saline-(bubble)-FITC Dx 2M) while the circles
and linear fit show the modified system with increased surface tension (4% albumin-
(bubble)-albumin-FITC Dx 2M).
3.5 Pressure measurements
Two techniques for measuring interstitial fluid pressure (IFP) are described below.
The wick-in-needle method allows IFP to be estimated within 1-2 mm Hg but without
optimal spatial resolution. The micropipette or servo-null method gives much better spatial
resolution and a more precise measurement, but is technically very difficult and therefore
not suitable for routine pressure monitoring. Micropipettes were therefore used to record
transient and spatial pressure changes in the tip of the tail following an intradermal
infusion. This is explored in Chapter 5, where such precision is necessary to support a
theoretical model of tissue fluid balance. The wick-in-needle is utilized in Chapter 7 for
daily measurements to detect gross changes in IFP, which were uniform spatially
throughout the tail, in experimentally created lymphedema.
3.5.1 Wick-in-needle
In this method, a wick-in-needle was prepared with a 26-gauge needle and four
nylon 6-0 sutures (Ethicon, Somerville, NJ). A small hole (approximately 1 mm diameter)
was created on the side of the needle, as depicted in Figure 3-6, using a small cylindrical
file. Pressure equilibrates at the hole made near the tip of the needle rather than the needle
opening itself to avoid artifacts due to needle clogging during insertion (Wiig et al 1986).
The needle was attached to PE-20 tubing filled with saline and connected to a pressure
transducer (Spectramed Model P23XL, Oxnard, CA). MacLab hardware and software
(ADInstruments, Australia) were used to output the readings from the pressure transducer
at a rate of 100 Hz. Body temperature of the anesthetized mouse was maintained with a
thermal pad (Shor-line #712, Kansas City, MO).
Figure 3-6. Wick-in-needle setup to measure IFP.
The wick-in-needle was inserted intradermally, nearly parallel to the tail, until the
side hole was completely immersed in the tissue. When the pressure reading stabilized,
fluid communication between the transducer and the interstitium was verified in the
following way. First, the tubing is squeezed slightly so that a minimal amount of fluid was
pushed into the tissue. If fluid communication is good, this causes a rapid increase in
pressure followed by an exponential decay back to the original pressure. Then the tubing is
released, instantly creating a drop in pressure which again returns exponentially to the true
pressure. Failure to return to the original pressure indicates poor fluid communication and
an unusable measurement; in this case the needle would be withdrawn, wicks changed, and
reinserted into another nearby location. Typical pressure readings from both good and bad
fluid communication tests are given below in Figure 3-7.
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Figure 3-7. Pressure recordings following the depression (A) and release (B) of the
catheter tubing to test fluid communication in the wick-and-needle setup in normal mouse
tail skin. Left: Good fluid communication is seen as the pressure returns to its original
position after both depression and release of the tubing. Right: When the tubing is
depressed, the recorded pressure changes as a step (in this case, it increased to over 300
mm Hg) and returns to an elevated pressure when released, indicating poor fluid
communication.
3.5.2 Micropipette
For more precise measurements of IFP, the mouse was placed on a thermal pad
under a stereo microscope (model SMZ-U, Nikon, Japan). A glass micropipette of
approximately 3-5 Lm diameter, connected to a servo-nulling pressure system (IPM model
5D, San Diego, CA) described previously (Boucher and Jain 1992), was introduced into
the skin approximately 2-3 mm from the needle tip and 300-400 microns deep. Once fluid
communication was achieved (in an analogous manner to that of the wick-in-needle) and an
initial baseline pressure recorded, the stopcock was opened to begin the infusion at a
pressure of 50 cm water. IFP was continuously recorded in the micropipette until a steady
state was achieved (i.e. pressure was constant within 2 mm Hg for at least 5 minutes),
resulting in a transient pressure curve. At this time the pipette was withdrawn and placed
approximately 1 mm further downstream from the infusion site for measurement of steady-
state pressure, and so on until at least 6 steady-state pressure values were recorded. The
relative position of the glass micropipette was accurately recorded using a micromanipulator
(IPM). Therefore, for each experiment both transient as well as steady-state spatial pressure
profiles were recorded.
3.6 Tissue area determination
The cross-sectional area of the tail, near the tip, was estimated histologically.
Sections from three mice were fixed, cut, and stained with 0.1% Toluidine Blue (Sigma).
A representative section was shown earlier in Figure 3-3. Each photograph was digitally
scanned and processed using NIH Image (NIH, Bethesda, MD). The total area was
measured along with that of the epidermis, bone, muscle bundles, and any blood vessels.
The dermal / subcutaneous fraction of total tissue area was thus calculated by subtracting
the other constituents from the total area. Therefore, to grossly estimate the cross-sectional
area for fluid flow in each experiment, the tail diameter was measured and multiplied by
this fraction.
The theoretical frameworks presented in the succeeding chapters relies on the
assumption that all fluid flow following an interstitial injection occurs in the dermal and
subcutaneous tissues. To support this assumption, tail cross-sections were stained for
collagen using a Masson stain and hyaluronic acid using a Periodic Acid-Schiff stain
(Bancroft and Stevens, 1982). These matrix proteins are primarily responsible for the
transport properties of the tissue, and in particular, glycosaminoglycan density (of which
hyaluronic acid is the predominant constituent) has been most closely correlated (inversely)
with hydraulic conductivity (Aukland and Reed 1993, Levick 1987, Grodzinsky 1983). As
shown in Figures 3-8 (a) and (b), the subcutis contains less collagen and hyaluronic acid
than the dermis, suggesting a higher hydraulic conductivity and lower elasticity in this
region. We therefore assume that most of the fluid flow following an interstitial injection
occurs in the subcutaneous space. However, there is no clear boundary between these two
tissue types, and they cannot be distinguished experimentally. Therefore the dermis and
subcutis will be treated as one composite tissue throughout this thesis, and transport
parameters will be considered as bulk-averaged parameters for mouse tail skin in a general
sense.
Figure 3-8 Matrix protein density in the mouse tail. B = bone, H = hair follicle, K =
keratin, E = epidermis, D = dermis, SC = subcutis, M = muscle. Left (a): Masson stain for
collagen. Other than bone, the dermis shows a higher collagen density than the
subcutaneous space. (b) Periodic Acid-Schiff stain for hyaluronic acid, which again shows
a higher density in the dermal layer, particularly close to the epidermis.
3.7 In vitro mechanical tests
For comparison with the in situ data of Chapter 5, in vitro stress-strain tests were
performed by confined compression using a Dynastat apparatus as previously described
(Frank and Grodzinsky, 1987) to estimate the elasticity of mouse tail skin under
compression. Tail skin was excised immediately after sacrifice by making two
circumferential incisions approximately 1 cm apart, joining them with a third axial incision,
and carefully 'peeling' the skin from the bone-tendon core using a hemostat and scalpel.
From this, a 3-mm disk was bored and placed in a confined compression chamber.
Placement was specifically epidermal-side down, with the assumption that the epidermis
has a higher elastic modulus than the dermis and subcutis so that the epidermal strain was
zero and stress (measured from the top) resulted from the relaxation of the dermal and
subcutaneous tissues only. Displacements of 25 gm were imposed and the resulting stress
measured for a total of 6 cycles each.
3.8 Model applications
In the following chapters, various aspects of the mouse model will be explored and
modified. First, flow within the lymphatic system is studied in Chapter 4, where fluid
pathlines and streamlines as well as net average flow are observed with different
techniques. Chapter 5 investigates the mechanical aspects of interstitial-lymphatic fluid
balance with a theoretical model and interstitial pressure measurements. Macromolecular
transport is explored in Chapter 6, where the tail is considered theoretically similar to a
chromatography column in order to estimate key transport parameters from observed
concentration profiles. Finally, Chapter 7 highlights other applications which are used to
elucidate the biology and pathophysiology of interstitial fluid balance and lymphatic
function, as well as assess a potential surgical procedure to relieve edema. The
experimental details of those studies will be described in each section of Chapter 7.
Chapter 4
Measurements of Flow Velocity'
4.1 Introduction
As seen in Figure 3-2, the lymphatic network of the mouse tail can be stained
progressively following an intradermal injection of fluorescently labeled tracer into the tail
tip. This chapter describes the initial development and characterization of this phenomena
and establishes the mouse tail skin model for quantitative investigations of interstitial-
lymphatic transport phenomena. Specifically, flow within the lymphatics was examined
both macroscopically and microscopically, and uptake was evaluated in a semi-quantitative
manner. Because of its regularity, apparent unidimensionality, and minimally invasive
nature, this model presented excellent potential for a variety of other applications, and is
continually modified and refined in succeeding chapters.
Consider the images in Figure 3-4. The staining of the lymphatic network is
dispersive and approximately one-dimensional, similar to flow phenomena in packed beds.
For these reasons, residence time distribution theory was utilized to evaluate macroscale
velocity and uptake. This analysis was then used to evaluate the roles of molecular weight
and injection pressure in lymphatic transport. In addition, a microscopic approach utilized
the technique of fluorescence recovery after photobleaching (FRAP) to establish local
instantaneous velocity and observe, on short time scales, streamlines of fluid movement in
individual vessels. Finally, 1-gm latex microspheres were used to visualize local flow
patterns (pathlines). Thus the process of lymph formation following an interstitial injection
was characterized on both macroscopic and microscopic scales so that local changes in flow
behavior could be correlated with overall net effects and a better understanding of transport
behavior within the lymphatic capillaries could be attained. This work established the
'This work is published in the companion papers Swartz et al 1996 and Berk et al 1996.
mouse tail skin model as a quantitative tool for studying initial lymphatic function and
interstitial-lymphatic phenomena. It was done in collaboration with Dr. David Berk.
4.2 Theory
4.2.1 Macroscale (average) velocity
The lymphatic filling patterns of Figure 3-4 suggests that the velocity of lymph
propulsion can be estimated by tracking the "moving front" of fluorescent tracer. However,
the front is not clearly defined due to dispersive effects as molecules enter the lymphatics
and travel through multiple pathways of the network. A plot of intensity vs. time for a
given small section of the network would result in an S-shaped curve as the intensity rises
from a minimum (background) to its asymptotic maximum; a typical plot is shown in
Figure 4-1. Both the extent of mixing within the network and the time required to establish
a steady state uptake rate of fluorescently tagged particles will determine the spread of this
curve.
The residence time distribution (RTD) theory of Danckwerts (1953) can be used to
analyze these transient intensity profiles and macroscopically evaluate the transient uptake
phase as well as the dispersion and mixing that the dye molecules experience as they travel
through the lymphatic network. The average time it takes a particle to reach a certain
distance from the point it was injected is referred to as the mean residence time (MRT). If
the dye were injected directly into the lymphatic vasculature, the slope of MRT vs. distance
would indicate the average velocity in the axial direction. If the dye were instead injected
into the interstitium, the MRT would include both the average time for a particle to enter the
lymphatics from the interstitium (i.e., uptake) in addition to the time to travel through the
network. Therefore, by examining the relationship between MRT and distance, the
behavior of the average axial velocity in the superficial lymphatics as a function of distance
can be observed, and a relative measure of uptake time can be obtained by extrapolating the
curve back to the injection site. This site is actually a region whose boundaries may change
throughout the experiment. Because it never extended more than 1 cm from the tip of the
tail using the experimental conditions described below, this distance was chosen to
encompass and define the injection site. The MRT at this intercept was then taken as a
semi-quantitative measure of the initial uptake rate. Its rigorous definition will be explored
in Chapter 5.
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Figure 4-1. Staining of the lymphatic network following intradermal injection of FITC-
Dextran 2M as measured by fluorescence intensity approximately 1 cm downstream from
injection.
The fluorescence measurements obtained in this way arise primarily from the
superficial capillary network; thus, the deeper unseen layer of collecting lymphatics is a
matter of concern. If the two parallel networks are completely uncoupled (except at
injection site), then the RTD analysis reveals nothing about the deeper lymphatics.
However, if a significant amount of flow occurs at the regular connections, it is likely that
the superficial network mirrors the same time course of lymph staining that occurs in the
deeper level.
If theta is the normalized concentration, assumed to be equivalent to the normalized
intensity (see Section 3.4), the MRT is given by (Danckwerts):
j Otdt
MRT - 0 (4.1)
f Odt
0
This is equivalent to the area above the normalized concentration vs. time curve:
MRT= f ftdt = (l - 6)dt (1 - 6)At (4.2)
dt o i=1
The MRT was calculated in this way for each distance.
4.2.2 Microscale (local) velocity
Lymph flow velocities in individual capillaries were measured by the method of
fluorescence recovery or redistribution after photobleaching (FRAP). A region of
fluorescent lymph was photobleached by brief exposure to focused laser illumination, and
the movement of the resulting darkened photobleached material was recorded in a series of
images immediately following. The monitoring of the photobleached spot (complicated by
light scattering in tissue) and determination of its center is previously described (Berk et al
1996).
4.3 Methods
Forty-four mice were used for these experiments: 10 for the determination of
network velocity, 8 for the size-dependence studies, 5 for the FRAP experiments, and 8 for
the microsphere injections. The basics of the experimental setup, including animal
preparation and intensity and flow measurements, are detailed in Chapter 3.
4.3.1 Macroscopic data acquisition and analysis
For the macroscopic examination of flow phenomena in the superficial lymphatics,
a 2.5X objective with a 1.25X eyepiece lens was used, resulting in field dimensions of 3
mm x 2.5 mm. Short pieces of suture were placed loosely across the tail at 1.0, 1.6, 2.2,
and 2.8 cm from where the needle tip would be positioned to provide markers for viewing
different sections of the tail. Each thin suture could then mark one side of a "window" (3
mm wide) along the tail so that eight consecutive windows could be accurately positioned
and analyzed at each timepoint. The first data point was taken just prior to beginning the
infusion for a background value. The light source was masked in the filter housing to
prevent unnecessary exposure and possible photobleaching. At each timepoint, the mask
was removed, illuminating the first segment or window (0.6 cm from the injection site).
The image was acquired into an image processing board (DT-IRIS, Data Translation,
Marlboro, MA), where the screen was divided into five vertical rectangles (2 mm x 0.6
mm) and intensity histograms were recorded for each. This was repeated for all 8 regions.
Thus, at each timepoint, the average intensity was measured in each of 40 consecutive
windows along the tail, spanning a length of 2.4 cm. These timepoints were taken every
ten minutes until the intensity change was less than 5% from the previous value (typical
time for the most proximal window was 3 hours).
From each histogram, the intensities from the brightest 5-15% of the pixels were
averaged. This is because the scattered light increases the "background" intensity (regions
between vessels) as the network fills with fluorescent material. By averaging only the
brighter pixels, intensity changes in the vessels alone can be averaged against an "initial
condition" background. Furthermore, because of occasional fluorescent particulate debris,
the brightest 5% of pixels were omitted from the average; however, it should be noted that
the results were not sensitive to the exact choice of these cutoff fractions.
To further characterize the model, the effects of particle size and injection pressure
on both uptake and network velocity were examined in separate studies. One study
involved the coinjection of two different dextrans, each with a different fluorescent label -
fluorescein- or rhodamine B-isothiocyanate (F1TC or RITC) - so that size effects could be
directly compared in each mouse. Two groups of four mice were compared: group A was
injected with a solution of FITC-Dx 71K and RITC-Dx 73K, and group B with a solution
of FITC-Dx 2M and RITC-Dx 73K. Both solutions contained 0.0125 g/ml of each dextran
in 0.9% saline. In vitro studies estimated the hydrodynamic radius of FITC-Dx 2M to be
18 nm and that of FITC-Dx 71K to be 6 nm, a threefold size difference. These are only
gross estimates which were obtained from FRAP measurements of the diffusion coefficient
(Berk et al) by assuming a Stokes-Einstein relationship between D and radius2.
2 The FRAP technique is described below in the next section, where it is used to calculate local convective
velocities in single lymphatic vessels. Here it is used to estimate diffusion coefficients in dilute, stagnant
The other study compared the effects of injection pressure on lymphatic uptake and
lymph propulsion velocity. Two different injection pressures were compared in five mice
each: 10 or 40 cm water (7.4 or 29.4 mm Hg). FITC-Dx 2M was used for this set of
experiments.
4.3.2 Microscopic data acquisition and analysis
To observe flow phenomena in individual capillaries, a 10X, 0.35 NA objective
with a 1.25X eyepiece was used. Two series of experiments were performed: visualization
of flow patterns with fluorescent microspheres and measurement of velocity using FRAP.
For direct visualization of flow in individual capillaries, microspheres of 1 mm
diameter were injected using relatively high pressure (approximately 5 ml in one second)
using a 25-ml microsyringe (Hamilton, Reno, NV). Because particles of this size cannot
freely move through the interstitial space, only a sudden and large local edema resulted in
uptake, so such injection conditions were necessary to observe spheres in the lymphatic
capillaries. Their movements were recorded on videotape 30 minutes after injection and
their oscillation frequency was counted by real-time observation. One mouse in this study
was tracheotomized and artificially ventilated3 (Harvard Apparatus Rodent Ventilator,
model 683, S. Natick, MA) at either 120 or 140 breaths per minute at a tidal volume of
0.15 ml/breath (Kleinman & Radford, 1964, Roscoe 1966) to examine the effects of
respiration on lymph flow.
The injection procedure for the FRAP experiments was identical to the less
disruptive method used in the RTD experiments described above (FITC-Dx 2M, injected at
a pressure of 40 cm water). FRAP measurements were initiated after sufficient fluorescent
fluorescent solutions in flat glass capillary tubes as described by Berk et al (1993). Then, the hydrodynamic
kT
radius is estimated by the Stokes-Einstein relation; i.e. r = 6
3 The mouse tracheotomy was based on a similar procedure performed in rabbits (Eckmann et al, 1997).
First, the throat tissue was dissected to the trachea. A curved hemostat was placed underneath to allow
control and manipulation of the trachea, and suture was drawn underneath with the hemostat. A
hemispherical cut was made perpendicular to the axis of the trachea using a size-15 scalpel. Using the
hemostat, a 3-cm length of sterile PE-20 tubing was inserted approximately 5 mm into the trachea, where it
was quickly and tightly tied with the suture. The PE-20 tubing was connected to a Y connector, which in
turn was connected via PE-50 tubing to the ventilator (one for inhalation and the other for exhalation). The
entire tracheotomy procedure lasted approximately 5 minutes, and the mouse was ventilated immediately
upon tracheal insertion of the tubing.
material appeared in the lymphatic capillaries (within 10 minutes). The FRAP apparatus and
details of the Fourier analysis of the images are described previously (Berk et al 1996).
The tail was positioned under the objective, and vessels were randomly selected in
the region 1 to 3 cm from the injection site. A capillary segment was positioned within the
microscope field of view so that its (radial) center fell within the previously determined path
of the laser beam. Regions near the intersection of several capillaries were avoided because
of anticipated complexities in flow patterns there. Within the 512 x 480 pixel video image,
a smaller rectangular region (10% to 25% of the total field) was defined to encompass the
capillary segment. An image of this region was digitized and stored, and then the laser
shutter was opened for a duration of 0.02 sec. Images of the photobleached spot were then
acquired at a rate of 6 images per second for approximately 4 seconds, followed by a rate
of one image per second for a total elapsed time of approximately 15 seconds. The distance
of the measurement site from the injection site were stored for later analysis. For each
mouse, approximately 20 to 30 of these photobleaching sequences were obtained over the
course of 90 minutes.
4.4 Results
4.4.1 Macroscopic (network) velocity and the effects of injection pressure
Representative MRT vs. distance plots for two mice, one characteristic data set for
each injection pressure, are shown in Figure 4-2. The MRT increased linearly with distance
in all cases for distances greater than 1 cm from the injection site, so linear regression was
used. The net velocity could not be measured in this way for distances greater than 3 cm
from injection because the concentration profiles become too diffuse to define a MRT.
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Figure 4-2. Representative MRT vs. distance data for each injection pressure. Here, the
velocity (slope) for the low injection pressure (P=10 cm H20) is 3.18 gm/s and intercept
(MRT at 1 cm, shown by the dotted line) is 74.3 min (r2 =0.906). For the high injection
pressure (P=40 cm H20), the velocity was 2.97 gm/s while the intercept was 39.6 min
(r2 =0.944).
Results comparing the two injection pressures are summarized in Table 4.1. Each
value represents the average of five mice. Not only was the slope (velocity) constant in
both cases, but there was no significant difference in velocities between the two injection
pressure groups (P=0.629 using Student's t-test). However, the relative uptake rates,
represented by the intercept (MRT at 1.0 cm), varied greatly between the two groups
(P=0.017). In addition, the average injection flow rates were significantly different
(P=0.0015): for the lower injection pressure, the mean injection flow rate was 15 ± 4
nl/min, and for the higher injection pressure it was 41 ± 11 nl/min.
Velocity (microns/s) MRT (min) @ 1 cm
10 cm H20 40 cm H20 10 cm H20 40 cm H20
minimum 1.36 2.77 66.6 33.7
maximum 6.13 5.27 149.0 52.1
mean 3.34 3.80 90.0 44.1
median 3.18 3.73 74.3 46.4
standard deviation 0.80 1.02 15.14 7.4
Table 4.1. Network velocity analysis data for injection pressures of 10 and 40 cm H20(n=5 for each group).
4.4.2 Effects of particle size
To evaluate the effects of particle size, the difference in MRT between the two
coinjected particles (RITC-Dx - FITC-Dx) was computed for each subregion. Assuming
the particles move with the same average velocity as the fluid, there should be no difference
between slopes of MRT vs. distance for each particle, and the differences in MRT would
be solely due to differences in uptake. Therefore, these differences at each subregion were
averaged for each mouse. The mean difference for group A, which consisted of two
dextrans of 71 / 73 kDa each (approx. 6 nm radius), was 1.6 ± 3.0 min. For group B,
which used different size dextrans of 73 and 2,000 kDa (6 and 18 nm), it was 2.4 ± 4.7
min. Neither of these were significantly different from zero according to a student's t-test
(P=0.24 and 0.28, respectively), nor from each other (P=0.81).
4.4.3 Microscale velocity in individual capillaries using FRAP
FRAP measurements were performed in five animals. A total of 130 velocity
determinations were made, of which 110 were judged valid based on the agreement
between the calculated spot path and the orientation of the lymphatic capillary. Figure 4-3
shows selected images from a typical photobleaching experiment, while Figure 4-4
illustrates the data obtained by spatial Fourier analysis of these images, with the calculated
path of the spot superimposed over the outline of the lymphatic vessel.
Figure 4-3. The photobleaching and subsequent recovery of fluorescent material in a
lymphatic vessel. a) FITC-Dx loaded capillary prior to photobleaching. b) Differential image
at t = 0.2 s after laser exposure. The photobleached region appears dark. c) Differential
image at t = 4 s. d) Differential image at t = 9 s. In b through d, the spot moves to the
bottom right corner of the image while it also dissipates. All figures are the same size scale.
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Figure 4-4. Spatial Fourier analysis of FRAP images. Left (a): The x and y coordinates of
the spot, calculated as described in the text, are plotted versus time to show the velocity.
Right (b): The path of the spot (symbols) is superimposed over the outlines of the
lymphatic vessel. In both figures, the origin refers to the centerpoint of the image.
The use of FRAP allows the fluid velocity in a single capillary to be measured at
different timepoints. In this series of experiments, it was difficult to discern a consistent
pattern that described the time dependence of velocity in individual capillaries. Figure 4-5
displays the behavior of 2 separate vessels. In one vessel which was perpendicular to the
tail axis or direction of net flow, the velocity is as rapid as 8 gm/s within the first 20
minutes of injection, falling to zero or slightly negative after one hour. In another vessel,
the velocity is consistently around 5 gm/s, except for a brief peak of 17 gm/s one hour after
injection was begun.
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Figure. 4-5. Instantaneous velocity within two individual capillaries as a function of time
during constant-pressure dye injection into the tail skin. One vessel was oriented
perpendicular to the tail axis and the other formed an acute angle with the tail axis.
A wide range of velocities were observed, from -19.46 to 28.96 gm/sec, with a
median of 3.43 jm/s and an interquartile range of -0.45 to 7.45 jim/s. Figure 4-6A shows
a plot of all velocity measurements in three different vessels of one particular mouse as a
function of time (from the beginning of the injection). The plot shows that at all times, flow
velocity is not uniform but spans a range that includes zero and negative (flow in the distal
direction) values. The plot also suggests that the absolute value of velocity is generally
greater in the initial phase of the experiment. Compiling all the experiments, an analysis of
variance test was used to compare measurements made in each of four half-hour time
segments. The decay of velocity magnitude was significant (p<0.0001), but appeared to
reach a plateau in the second hour, as illustrated in Figure 4-6B. A similar analysis of the
correlation between velocity and distance from the injection site revealed no obvious
dependence.
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Figure 4.6. Relation between velocity
magnitude and time of dye infusion.
Top (a): Compilation of velocity
magnitudes collected in one mouse.
Each symbol denotes the
measurements from one of three
vessels. Left (b): Mean and standard
deviation of values from all velocity
magnitudes collected (n= 111),
grouped into 30 minute time
segments. The decay is significant
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4.4.4 Flow visualization using microspheres
By injecting 1-gm latex spheres, flow patterns could be directly visualized in five of
either mice simply by following the motion of individual spheres (Figure 4-7). In all five
cases, the spheres were observed to oscillate at an average frequency of 125 per minute.
This frequency which correlated closely with respiration rate (115-145 per minute) rather
than heart beat (over 200 per minute) or vasomotion (2-10 per minute). Because of this,
one mouse was ventilated artificially so that its respiration rate could be controlled and
altered. The oscillations of the spheres correlated exactly with a ventilation rate of 120 per
minute, and when this frequency was increased to 140 per minute, oscillation frequency
also increased to 140 per minute.
Figure 4-7. Images of fluorescent microspheres in the superficial lymphatic capillaries of
the mouse tail skin. Their non-optimal focus is the result of light scattering from a depth of
approximately 100-200 gm below the surface. Total width of the image is 375 Lm.
4.5 Discussion
Unlike blood vessels, in which net flow velocity can be measured as well as
streamlines and pathlines observed simultaneously with the red blood cells, the lymph has
no such natural markers for fluid movement. In this chapter, novel fluorescent techniques
were developed for examining lymph flow both on macroscopic and microscopic scales.
Uptake and net axial flow velocity were characterized using RTD theory by following the
dispersion of an injected tracer. Local details of flow in individual capillaries were
evaluated using FRAP and microsphere injections. These techniques not only allow new
types of investigations into lymphatic physiology, but they are also useful tools for cell
trafficking studies. For example, FRAP can be used to estimate shear stresses in lymphatic
capillaries and thus evaluate cell adhesion.
RTD theory proved to be accurate and appropriate for a first-order characterization
of the net velocity and uptake; by integrating a dispersed intensity curve over time, the
average time for a particle to enter the initial lymphatics and travel a given distance within
that network can be calculated. Uptake and flow times can be resolved, and a net velocity
can be determined by comparing this average time with distance. The underlying
assumption that the velocity of a tracer molecule represents the fluid velocity within the
lymphatic capillaries (but not within the interstitium) is supported by the fact that a linear
relationship exists between MRT and distance. The assumption is further supported by the
FRAP studies, which accounted for dispersive effects independent of velocity. This simple
analysis permits investigations of the effects of various physiological factors on lymphatic
function, and we have shown here examples of particle size and injection pressure.
Pilot studies showed that initial uptake is independent of injection concentration at
injection pressures of 10-40 cm H20. This was done as an experimental control to ensure
that fluid uptake was convection-dominated and that the interstitial concentration imposed
by the injection did not affect the uptake rate of fluid in the range of experimental conditions
used. Furthermore, the results from the size study indicate that, in such convective uptake,
the lymphatic endothelium did not pose a size barrier to the macromolecules in an
approximate range of 6-18 nm radius. Since the uptake time also reflects the interstitial
transport time, and since such a size difference is unlikely to travel through the interstitium
in the same way, the limitations of the technique are exposed. In other words, while the
technique is good at quantifying intralymphatic flow phenomena, it shows little sensitivity
in distinguishing interstitial transport phenomena such as size partitioning. A more refined
approach to interstitial macromolecular transport is addressed in Chapter 6.
The technique can give valuable insight into the physiology of lymph propulsion,
however. Results comparing injection pressures suggest that while uptake and infusion
flow rates depend on local tissue pressure, the net velocity of lymph (at least at the capillary
level) does not. Unlike blood vessels, lymphatic capillaries have no smooth muscle and
rely on elastic fibers which anchor their endothelial cells to the extracellular matrix to
prevent collapse. As tissue swells, lymphatics are pulled open to create spaces for drainage.
Furthermore, the capillaries drain to deeper vessels which have valves and smooth muscle
but are nonetheless noncylindrical and easily distensible. Because of these features, it has
been suggested that the lymphatics have an enormous capacity for drainage which is far
beyond normal physiological requirements and that drainage rate depends linearly on IFP
for up to at least ten times normal rates (ref). Our observations that interstitial fluid pressure
and infusion flow rate do not affect lymph propulsion velocity support the idea that
systemic rather than local forces govern lymph propulsion, and that velocity is independent
of volumetric flow rate.
If net velocity is indeed independent of net flow, a simple mass balance might imply
that the cross-sectional vessel area must change, possibly by vessel recruitment or diameter
adjustments. This hypothesis is supported by our observations that the vessels appear
larger, or more swollen, with higher injection pressures. However, only the net velocity in
the superficial vessels has been measured in this study. Since the larger vessels may offer
less resistance to flow than capillaries, velocities in these vessels may depend on uptake
rate; such a theory cannot be postulated based on this experiment alone.
The microsphere studies, however, support the above hypothesis by showing that
pressure changes due to expansion and contraction of the chest cavity are transmitted to
lymphatic capillaries, possibly by creating a slight pump in the thoracic duct. For decades it
has been observed that respiration affects lymphatic flow near the heart: it was observed as
early as 1939 that forced expiration increases lymphatic pressures while inspiration causes
a fall in pressure (Cressman and Blalock 1939); it was also shown that the highest lymph
flow rates in the thoracic duct occurred at the end of inspiration (Browse et al 1974). The
fact that these effects are seen in the tail, immobilized and isolated from the chest wall,
suggests that respiration may induce a pressure drop in the major lymph vessels and create
a pump throughout the entire lymphatic system.
FRAP measurements reveal a number of complexities of lymph flow that were not
apparent with the integrative approaches of residence time analysis presented here. The
broad range of velocities detected by FRAP shows that a large number of individual
measurements must be made in order to characterize the lymphatic capillary network as a
whole, and even so, sampling of the network is limited to geometrically and optically
advantageous regions and cannot be completely random. However, the FRAP
measurements display two important facts. First they show that despite the net flow in the
proximal direction, individual capillaries may exhibit retroflow or stagnation. Second, the
mean magnitude of velocity decays with time, but the rapid flow is not necessarily
proximally-directed.
One interpretation of these observations is that the injection causes large local
pressure gradients and filling of portions of the network along preferential pathways,
followed by the lateral or even retro filling of the more flattened or obstructed vessels so
that complex flow patterns develop. At later times, the capillaries are more uniformly
dilated and more vessels are involved in transport, so the average velocity is lower. The
record of velocities in two individual capillaries shown in Figure 4-4 supports this
hypothesis. One vessel, oriented normal to the tail axis, has a large initial velocity that
declines to near zero. This may reflect lateral filling of the network due to the effects of
local injection. The other vessel shown in the figure is more nearly parallel to the tail axis,
and it maintains a more uniform velocity throughout the experiment. The velocity in this
case is more clearly related to the transport of lymph away from the injection site, and
therefore it suggests that flow is driven by a more constant systemic force.
The RTD analysis allows calculations of net velocity averaged over space and time.
For comparison, therefore, FRAP velocities were averaged in each mouse. The mean
average of local velocities was found to be 4.7 jim/s. Since the RTD method measures a
net velocity parallel to the tail axis, tortuosity needs to be accounted for when comparing
the averages of each method. By considering the capillary network as a regular hexagonal
mesh, the tortuosity factor was estimated to be 1.17; with this correction the average vessel
velocity parallel to the tail axis is 4.0 tm/s. This correlates well with the observed
macroscopic or net velocity of 3.8 ± 1.0 irm/s, especially considering that velocities were
only measured in vessels and not vessel intersections (which would further reduce the true
FRAP average). Because the macroscopic velocity is the net sum of all the individual
capillary velocities, the two independent characterization methods support each other. Note
that since the FRAP measurement takes place over a much longer time scale than the
oscillation frequency (approximately 40 breaths over the measurement), oscillation effects
cannot be detected by FRAP.
While these two methods are in agreement, the information each gives is
complementary to the other. The RTD method allows us to examine a net steady-state
velocity, which has relatively little variation because it is measured over a long distance;
this is useful in considering net physiological aspects of lymphatic transport. FRAP, on the
other hand, accurately measures velocity in single capillaries, which varies greatly between
vessels. While the RTD velocity is useful for revealing relationships between pressure,
flow, and uptake, FRAP is more appropriate for observing changes in local flow behavior
or for studies in which a local velocity is necessary. Furthermore, the microspheres allow
long-term flow visualization and fluid pathlines to be observed. In contrast, FRAP creates a
transient tracer population that dissipates with time.
Chapter 5
Interstitial-lymphatic fluid balance'
5.1 Introduction
In chapter 4, a quantitative model was established for investigating interstitial-
lymphatic transport phenomena. RTD theory was used to follow fluorescent tracer
movement, assumed to be related to fluid movement, and revealed a characteristic time
associated with lymphatic uptake which depended on infusion pressure. Now that the
experimental model had been established, the next step was to investigate more closely the
mechanics of fluid balance.
Interstitial-lymphatic fluid movement is complex and poorly understood. Previous
works constitute an incomplete picture, but provide enough evidence to postulate a
theoretical basis for mechanical interactions within the tail skin model. We therefore
attempted to incorporate known anatomical and physiological features of the lymphatic
system into a mechanical framework of tissue fluid balance so that simple experiments in
the mouse tail skin model could be used to quantify tissue transport parameters. Such a
model would potentially be of key importance in exploring changes associated with
lymphedema, for example, as well as any other alteration in tissue fluid balance which can
be experimentally created in the mouse tail.
It has been established that interstitial fluid volume (IFV) and interstitial fluid
pressure (IFP) both affect lymphatic flow (Hogan and Unthank 1986, Mortimer et al 1990,
Aukland and Reed 1993, Granger 1979), and depending on the compliance and state of
hydration of the tissue, IFP usually determines IFV. A swelling tissue may exert tensile
stresses on the lymphatic endothelia via anchoring filaments (Leak 1976, Ryan 1989,
Castenholz et al 1991a, Schmid-Sch6nbein 1990) to locally increase drainage during acute
Part of this work is included in Swartz, MA, PA Netti, C Brekken, Y Boucher, and RK Jain. Mechanics
of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. (In press)
swelling. Furthermore, the anchoring filaments are structurally and molecularly similar to
the elastic fibers of the extracellular matrix, suggesting functional continuity with the
interstitium (Gerli et al 1991). External stresses such as massage can temporarily increase
local drainage as well as internal factors which transmit mechanical signals through the
tissue (such as vasomotion, muscular activity, and respiration) to influence lymphatic
clearance (Negrini et al 1994, Aukland and Reed 1993, Schmid-Schanbein 1990). Clearly,
lymphatic function is intrinsically and dynamically coupled to the interstitium. Previous
evaluations of lymphatic function, however, have largely neglected the dynamics of the
interstitium. Furthermore, most biphasic models of tissue mechanics (Mow et al 1984,
Grodzinsky 1983, Barry and Aldis 1990, Holmes 1986, Jbnsson and J6nsson 1992, Blake
1989) typically describe cases in which lymphatic drainage does not play a key role in
fluid-solid tissue equilibrium.
In this chapter, the relationship between tissue fluid balance and lymphatic function
is explored by incorporating a relevant theoretical framework with the mouse tail skin
model (for experimental details, see Chapter 3). The continuous interstitial infusion into the
tip of the tail creates gradients in pressure and stress within the interstitium. The spatial
profiles of these gradients depend on the hydraulic conductivity of the tissue as well as the
overall drainage capacity of the lymphatics. Temporal gradients depend additionally on the
tissue elasticity. This relationship is depicted in Figure 5-1. A poroelastic description of
interstitial-lymphatic fluid convection was developed to predict the hydrostatic pressure
distribution within the tissue according to its elastic properties and the overall functioning
of the lymphatic system. The theory is substantiated with measurements of pressure in the
mouse tail following an infusion of saline. Also, in vitro measurements of the elastic
modulus are used to support the in vivo data. Confined compression tests were performed
in the laboratory of Dr. Alan Grodzinsky and are described in Section 3.7. This framework
allows us to evaluate the relative resistances to fluid transport as well as to estimate in situ
the hydraulic conductivity of the tissue, its elastic modulus, and an effective resistance to
lymphatic uptake. More importantly, it provides a tool in which the mechanisms of
interstitial-lymphatic fluid transport can be distinguished and evaluated quantitatively.
Finally, it forms the necessary foundation for analogous studies of interstitial-lymphatic
molecular transport.
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Figure 5-1. Mechanical aspects of tissue fluid balance.
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Modeling foundation
A step increase in IFP at the tip of the tail results in a transient response 3.2 mm
downstream which is shown in Figure 5-2. In a rigid porous matrix, we would expect a
pressure wave to travel at the speed of sound in water. In the tissue, however, the
characteristic time for mechanical equilibration is shown below to be on the order of 8
minutes. In order to describe this transient response, therefore, the tissue cannot be treated
as a rigid porous matrix and the elastic component of the interstitium must be accounted for
which responds to stress (pressure) with a resulting strain (swelling). It is the elasticity of
the tissue which determines this stress-strain relationship, and the speed of propagation of
stress or strain depends on the tissue's elastic modulus.
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Figure 5-2. Interstitial fluid pressure (dots) measured approximately 3.2 mm downstream
following a step infusion of saline at 52 cm water (38.5 mm Hg). Plus symbols show the
infusion pressure measured in the infusion line.
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5.2 Theory
5.2.1 General
In the following analysis, gradients in tissue stress resulting from an interstitial
injection are described by a balance between interstitial flow and lymphatic function. A
poroelastic framework is based on a previously developed model to describe fluid
movement in solid tumors with capillary reabsorption (Netti et al 1997); here the focus is
on the role of the lymphatics in controlling this mechanical relationship.
The tissue is regarded as a fluid-filled, porous elastic solid matrix. The fluid and
solid phases are each inherently incompressible and tissue deformation is described as a
change in fluid volume fraction E. The two phases are thus assumed to exist in mechanical
equilibrium. Considering the tissue continuum, a quasi-static stress balance is assumed:
V-=T 0 (5.1)
where Tis the tissue stress tensor.
A constitutive law is needed to define the stress tensor and approximate the elastic
behavior of the solid matrix. For fast deformation, the stress-strain relationship may show
time-dependent behavior and thus require a viscous component in the constitutive law.
However, if the deformation is slow enough, quasi-static stress-strain relationship may be
assumed. This infinitesimal strain approximation results in linear elastic behavior:
T = -PI + Ael + 21E (5.2)
where P is hydrostatic (thermodynamic) pressure, I is the identity tensor, e is the dilatation
of the solid phase, E is its strain tensor (Cauchy infinitesimal strain, not to be confused
with the fluid volume fraction e), and A and y its intrinsic elastic (Lam6) constants. If u is
defined as the solid displacement vector, then the dilatation is given as
e=V.u (5.3)
and the strain tensor is
E-1/2 (Vu + Vu T).
Therefore, e= Tr(E) and is dimensionless. Since the experimental model utilizes a slow
interstitial infusion (on the order of 0.1 l/min, or 1% tissue volume comprising the
characteristic length per min) into a low-compliant tissue, small gradients in hydration and
thus small strains of the interstitial matrix are inferred. This is verified a posteriori.
For a symmetric system, the isotropic normal stress (i.e., pressure) can be related
to the dilation of the solid matrix:
0=V.T
= V .(-PI + Ael + 21E)
= V. (-PI + A(V. u)I + /(Vu + VuT ))
= -VP + Ve(2 + A)
Thus,
VP = (2y + t)Ve. (5.5)
Therefore, the parameter (2 u + A) represents the effective bulk elastic modulus and
is usually denoted as H in the literature (Fung 1981). Assuming the mutual drag forces
between fluid and solid phases are linearly proportional to the relative velocity through the
matrix, a generalized Darcy's Law is used to describe the bulk interstitial fluid movement:
E f- = -KVP (5.6)
where f is the average pore fluid velocity, i the average solid displacement, e is the fluid
volume fraction (not to be confused with the strain tensor E) and K the intrinsic
permeability or hydraulic conductivity of the tissue matrix (per gram of tissue). In other
words, K relates the relative bulk fluid velocity (relative to the solid) to the pressure
gradient. In this form, K represents an intrinsic tissue conductivity, independent of the
cross-sectional area.
(5.4)
In the following analysis, K is assumed constant because within the characteristic
length of the infusion, swelling should be maximal and therefore changes in the parameters
small compared to their values. In this way they represented bulk-averaged parameters in
the infusion region, where all of the measurements were made. As seen from the results,
these assumptions proved relevant and valid for the experimental model used and the
conditions imposed. For other purposes, e.g. smaller pressure gradients or more compliant
tissues, modifications to the theoretical framework may be necessary. In fact, a functional
form for K does not need to be specified until a solution is desired (Equation 5.16). For
example; if changes in hydration are significant, K may be written as a function of e:
K = KO (5.7)
as observed in vitro (Bert and Fatt 1970, Levick 1987, Mow et al 1986
Continuity equations for the fluid and solid phases complete the description. Let Pf
and p, denote the fluid and solid fractions, respectively. If fluid mass is conserved except
for that which is drained by the lymphatics, and solid mass is conserved, we have
SV -(pf ) - JvPtissue
and
dp+ V dt 0,dt (P - =0,
where J is the net lymphatic drainage or volumetric flux (i.e. J [=] vol. lymph formed per
unit tissue volume per time). Since pf = Pi,,,,,ue and p, = (1- e) Ptsse,,, these become
- + V - (EF) = -J, (5.8)
dt
and
- --+ V. (1- e) O- = 0. (5.9)
dt dt
These are then combined to give a total continuity law
V. (1-e)- -+ei7 = -J,. (5.10)
Regardless of its physiological mechanism, the flux J, represents a sink for
convecting fluid and would require a relative density of lymphatic capillaries large enough
to maintain the tissue continuum approximation. Although the lymphatics are primarily
responsible for the fluid uptake following an intradermal injection, the flux term must
incorporate all mechanisms of fluid drainage such as capillary reabsorption. Furthermore,
the representation of lymphatic drainage as a disappearance of fluid pressure implies that
although the lymphatic vessels themselves may occupy space in the tissue continuum, any
changes in their volume are negligible. In other words, the rate of fluid entry into the
lymphatics is assumed to equal the volumetric fluid flux within the lymphatics at any given
cross-section of tail.
In defining the lymphatic flux, the local and systemic mechanisms are combined in
series. Because of the high permeability of the lymphatics and isotonicity of the infused
solution, it is assumed that hydrostatic pressure differences dominate the Starling fluid flux
across the lymphatic capillary wall:
Jv(stariing) = Lp S/V(Pi - Pl) (5.11)
where LP is the average permeability of the lymphatic capillaries (vol-area'-time-'-mmHg'),
S/V is their average density (ratio of surface area to tissue volume), and Pi and Pt are
interstitial and lymphatic pressures, respectively. We assume that the interstitial pressure
imposed by the infusion is much larger than normal IFP in the anesthetized animal
(Aukland et al 1984, Aukland and Reed 1993, Schmid-Sch6nbein 1990, Zaugg-Vesti et al
1993) and thus dominates the forces which drive lymphatic uptake. Finally, we represent
fluid drainage from the capillaries into the deeper lymphatics as driven by a pressure
difference PI-Pb, where Pb is a hypothetical baseline pressure resulting from the various
factors which collectively contribute to the systemic lymph pump. These factors include
myogenic activity of the collecting lymphatic vessels, muscular movements, and respiratory
oscillations (Granger 1979, Aukland and Reed 1993, Schmid-Schdnbein 1990, Negrini et
al 1994). This baseline "pressure" maintains the driving force for systemic lymph
circulation and will be considered constant (i.e. systemic lymph flow is unaffected by the
perturbation at the tail tip). If the drainage rate of a lymphatic capillary is much slower than
its filling rate, P will be close to Pi and flux will be limited by the capability of the deeper
lymphatics to pump and drain lymph rather than local Starling forces. By lumping these
together into a total resistance term Rt, the local lymphatic uptake rate can be considered
proportional to P- Pb , or P*, accordingly:
., = P(i - Pb) = PP* (5.12)
where 3 represents the effective "conductance" for lymphatic uptake (vol. lymph-vol.
tissue- -time-'.mmHg-'). Considering an overall resistance to uptake, Rt or 1/p is then the
sum of the resistance to lymphatic drainage in series with the net systemic resistance Rs:
1 / 1 /S= t = SV + Rs (5.13)
(LP S/V
Thus, the major assumption here is not that intralymphatic pressure is constant but rather
that systemic forces maintain an overall constant resistance to flow.
Coupling Equations 5.10 and 5.12, the continuity equation for the tissue can be
expressed as:
P =V- (E - 1) - )i
d (V-)( E(V - V )
= (E - 1) de - e(V - ) (5.14)
where P* is the difference (Pi-Pb).
Returning to fluid momentum, the divergence of Eq. 5.6 yields:
orV F _ (V.,) = V -(KVP*)
or
eV - - e- = -KV 2 * - VK -VP* (5.15)
Note that the functionality of K has not been specified and thus the possibility to
include specific cases of variable K is maintained. However, if we assume that
KV2P * >> VK. VP*, which would be a reasonable assumption for normal skin with
moderate values of elasticity, then the last term on the right-hand side of Eq. 5.15 can be
neglected. Hydration, or isotropic strain, is related to interstitial pressure by the elastic
modulus (2pu+A); i.e. -- = (2y + A)- 1. If K is related to strain by Eq. 5.7, then
dK _ E b-1 (dE Kb
dP - K  -E 1-e) = e(1 - e)(2u + )
For the condition KV2P >> VK. VP' to hold in 1-D space, it must be true that
d 2P* dK (dP* 2K >> .-p - d
This is approximately equivalent to
P * Kb P *2
x e(1- e)(2g + A) x 2
or, simply, E(1 - e)(2u + A) >> PP*. For illustration, let us take approximate values which were
found for normal mouse tail skin (see Section 5.3): for an applied P* of approximately 10
mm Hg, (2u+2) was on the order of 102 mm Hg. A typical value for b is 0.5 (Bert and
Reed 1995), and e is on the order of 0.5. With these values, the inequality holds.
However, for edematous tissues, e and b increase while (2u+A) decreases, disputing the
validity of this simplification. This is explored in Chapter 7.
If we do neglect this last term, then Eq. 5.15 can be combined with the continuity
and stress-strain relations (Equations 5.14 and 5.5, respectively) to yield the governing
equation for tissue strain:
de K(2 + A)V 2e + fP* =0 (5.16)dt
5.2.2 Application to the experimental model
The mouse tail is an ideal experimental model both from a practical as well as
theoretical point of view. If we consider the tail as a long, thin rod2 (1-2 mm diameter)
composed mainly of dermis and subcutis between an epidermal layer and bone (Fig. 3-4),
an approximate one-dimensional pressure gradient can be induced in the dermal-
subcutaneous layer by inducing a step change of pressure at the tip. By measuring the IFP
with a micropipette, the response of the tissue to this step change, both transient and
spatial, can be evaluated. Theoretically, this system is advantageous in many ways. First,
only axial gradients are considered, assuming that radial strain (and thus IFP) equilibration
is fast compared to that in the axial direction. This assumption is justified by a simple
scaling analysis (the radius is an order or magnitude smaller than the characteristic axial
length, which will be verified a posteriori) and frees us from making assumptions about
isotropic transport parameters in the tissue. Also, the induced pressure gradient dominates
any baseline physiological fluctuations in pressure as well as the estimated changes in
osmotic pressure which makes it the primary driving force for convection. Finally, since
fluid is injected into the tip and can only travel in the proximal direction (presumably within
the dermis and subcutaneous space), it constitutes a geometrically closed system.
First we need to relate the measurable quantity - interstitial fluid pressure - to the
tissue dilatation of Equation 5.16. We saw from Eq. 5.5 that VP* = (2 /M + A)Ve, but the
time dependence of P needs to also be related with that of e. Starting from Eq. 5.5,
d (VP*) = (2u + ) d(Ve).
2 The tail has approximately uniform diameter between 0.5 and 2 cm from the tip, which is well within the
region of measurement or characteristic length.
For a one-dimensional system,
dd dP*
= (2 + A) (de
and upon integration,
dPx
dtx
=(2p +/) d
dt
Since the tissue is considered a semi-infinite medium, we have the condition that as
dP*
X 
-> 00' dt
0e
- 0O. Thus, f(t) = 0 and the governing equation can now be expressed indt
terms of pressure
1  dP* d 2p*
(2p + A) t d-X +P =0
with the conditions of a step increase in pressure at the boundary
P* (0, t)= P ,
P*(,t)= 0,
(5.17)
(5.18)
P*(x, 0) = 0,
where P is the applied pressure (Po - Pb). Thus, the distribution of pressure is governed
by the "stress diffusivity" or effective fluid conductance, K(2p+A) or K*, and overall
lymphatic conductance, 1(2p+A) or 3*. Here the ratio a = /Ikl is introduced as a
characteristic penetration length to describe these relative resistances to fluid transport and
which governs the steady-state pressure profile.
The analytical solution to Equations 5.17-18 was first solved for heat conduction in
a thin wire, where convection is approximated as a homogeneous generation term for high
+ f(t).
Biot numbers (Carslaw and Jaeger 1947), and then for chemical diffusion and adsorption
into a semi-infinite medium by Danckwerts (1953). This is:
P*(xt) l= e-erfc x t+ ex/aerfc x + (5.19)
Po 2 2 K t 2 2-4K t
According to this model, the steady state pressure (Ps) will decrease exponentially
with distance according to the ratio of tissue to lymphatic conductivities (a):
P = Po*e- a (5.20)
If the tissue poses a much greater resistance to fluid transport than the lymphatics, we
would expect a steep pressure profile within a short penetration depth; conversely, if the
lymphatics were nonfunctional, IFP would eventually become constant everywhere.
Therefore, by measuring transient and steady-state pressure profiles, the quantities
K(2gp+A), P(2M+A), and their ratio a2 can be estimated. Because the speed of pressure
propagation depends intrinsically on the tissue elasticity(2+A), the transport parameters K
and P cannot be separated. However, their product can be estimated from a total mass
balance on the injection. Since injected fluid moves through the tissue until it is taken up by
the lymphatics (or blood circulation), the net flow rate Q into the tail must equal the total
lymphatic uptake rate integrated over the tail.
Q f f P* -A, dx.
Here, AC is the cross-sectional area of the tail through which fluid flows, assuming that
dermal and subcutaneous tissue poses less resistance to flow than the other local tissue
compartments, and is estimated from stained images of tail cross-sections. This can be
evaluated at steady state:
QS f P e-a -AC -dx = Ac iKP* (5.21)
0
Thus, by measuring the injection flow rate along with the steady-state pressure profile3 , a
complete analysis of the system is provided and the estimation of each parameter is
possible.
5.2.3 Special case of oscillating pressure
In addition to a step increase in pressure at the boundary, the system was analyzed
for the condition of oscillating boundary pressure, since natural intrinsic stresses within a
tissue are typically oscillatory. Although these were not explored experimentally because of
technical feasibility, the theoretical pressure profiles and total uptake rates in oscillating
stress conditions were compared with those from the constant pressure boundary
condition. Oscillations were imposed about the same pressure magnitude:
P*(0,t) = Po,(1 + sin ot), (5.22)
Duhamel's Theorem (Carslaw and Jaeger 1959, p.31) can be used to solve Equations 5.17
and 5.22:
P t P* (t - p)Pose = (1 - sin cp) d p; (5.23)0 d dq,; (5.23)
0
where P* is the constant-surface pressure solution from Equation 5.19. The total fluid flow
rate, or total lymphatic drainage rate, is then
SP* (t - )TQoc (t) = f f (1 - sin o ) d dx. (5.24)
00
3 Theoretically, all three parameters could be evaluated simply from the initial transient profile of injection flow rate:
Q(t) = -KA dx =0
-KA 1 l (1-e-(2+))+ 1 erf( _(2y + )t)"
=- 4~(fK(2 + A) a
However, because of the lack of a sensitive flow meter, this is not experimentally feasible.
Pressure profiles and flow rates were computed numerically using the parameter values
given in Table 5.1.
5.2.4 In vitro elastic modulus
For comparison with the in situ data, in vitro stress-strain tests were performed by
confined compression using a Dynastat apparatus as previously described (Frank and
Grodzinsky 1987) to estimate the elasticity of mouse tail skin during compression. Tail
skin was excised immediately after sacrifice by making two circumferential incisions
approximately 1 cm apart, joining them with a third axial incision, and carefully 'peeling'
the skin from the bone using a hemostat and scalpel. From this tissue, a 3-mm disk was
bored and placed in a confined compression chamber. Placement was specifically
epidermal-side down, with the assumption that the epidermis has a higher elastic modulus
than the dermis and subcutis so that stress (measured from the top) resulted from the
dermal and subcutaneous tissue only. Displacements of 25 gm were imposed over a period
of 15 seconds and the resulting steady-state stress measured for a total of 6 displacements
5.3 Results
5.3.1 Tissue fluid balance parameters
Results of pressure propagation from a typical experiment are shown in Figures 5-3
and 5-4. The ratio a was estimated by fitting the spatial pressure profile to Eq. 5.20.
Furthermore, the intercept (relative position where P=Po) determined the infusion "origin"
(x=O) from which the transient positions could be adjusted accordingly.
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Figure 5-3. Spatial pressure profile from a typical experiment (the same as shown in Figure
5-2) after a steady state had been established.
In all experiments, the steady infusion flow rate (which stabilized after no more
than 10 minutes in all cases) was linearly proportional to infusion pressure in the range
used, and, according to Eq. 5.21, resulted in estimates of /3 and K when combined with a.
The cross-sectional area A c, determined by analysis of histological sections (Figure 3-4),
was found to be 65±4% of the total tail cross-section (7td 2/4). For the 5 mice used in the
experiments, this area was determined from diameter measurements at approximately 1 cm
from the tip and averaged 0.8±0.2 mm 2 (mean ± s.d.). Diameter was unchanging, to the
precision of our measurement, within injection region (2-10 mm). The pressure-flow
relationship from this particular experiment is shown in Figure 5-4.
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Figure 5-4. Typical data showing the dependence of infusion flow rate on infusion
pressure.
Finally, using these values for x and a, the transient profile was fit to Equation
5.19 using Matlab (Mathworks, Inc., Natick, MA) to determine the pressure diffusivity
K* =K(2+AZ) . The fit to the data is shown below in Figure 5-5.
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Figure 5-5. The transient IFP profile at 3.2 mm (the same data as shown in Fig. 5-3),
normalized to the infusion pressure, and its fit to Equation 5.19 (solid line).
Results from the 5 experiments are summarized in Table 5.1. Baseline pressures were
measured approximately 1 cm from the tip of the tail. Individual data from each experiment
is given in Appendix B.
Mean + s.d.
Baseline pressure Pb 9 ± 6
(mm Hg)
Infusion flow rate for 50 cm water 2 ± 1 x 10-3
(37 mm Hg) infusion
(l/sec)
Steady-state ratio a = 4K/-f 0.23 ± 0.07
(cm)
Effective lymphatic conductance P 4 + 2 x 10-
(sec 1 • mm Hg 1')
Interstitial hydraulic conductivity K 1.5 ± 0.4 x 10-6
(cm2 * sec -1 mm Hg 1')
Tissue elasticity 2u+A, 110 ± 20
(longitudinal modulus)
(mm Hg)
Table 5.1. Results of 5 experiments with infusion pressures of 40-60 cm water.
Although a wide range of baseline pressures and infusion flow rates was measured among
the experimental animals, a remarkable consistency is seen for their gradients and therefore
the calculated parameter values. The sensitivities of the theoretical fit to the parameters a
and K* are shown in Figure 5-6.
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Figure 5-6. Sensitivity analysis of the transient pressure profile on the variables given in
Eq. 5.19. The solid line is the normalized pressure profile, where p. = P* P-
, P id-P
using the parameters obtained from the data in Figure 5-4 (i.e. the best fit of this data). The
dotted line shows the sensitivity of this profile to the ratio a = ;K1, or a normalized
dP* a, P' and controls the steady-state value of the pressure (important at longer times).ja* P' da
On the other hand, the parameter K* = K(2 +A) governs the initial shape of the pressure
propagation and dominates the initial reaction, and is shown by the dashed line
dP** K0 dP*
dK' PP da
5.3.2 In vitro parameters
After the application of a fixed strain in the confined compression tests, the load
was recorded as the fluid was drained from the tissue. The steady-state stress is then related
to the unidirectional solid displacement u x by the elastic modulus:
duxtx = (2 +A) dux (5.25)
dx
The stress responses of the confined compression tests were measured for 6 successive
displacements to estimate the modulus. This parameter was fairly consistent for up to 20%
compression for 4 tests. (2u+A) was found to be 240 ± 60 mm Hg (mean ± s.d.).
Considering the important differences between the in vitro and in situ measurements, such
as excised vs. living tail skin, radial vs. axial strains, and compressive vs. swelling
stresses, the results from the confined compression tests serve to give validity to our in situ
model and are discussed in the next section.
5.3.3 Oscillating surface pressure simulations
When an oscillating pressure is imposed at the boundary, it propagates within the
tissue in an analogous manner to that of constant pressure. As seen in Figure 5-7(a), an
oscillating pseudo-steady state is achieved, which leads to oscillating drainage rates (Figure
5-7(b)). As expected from the theoretical foundation, these drainage rates yield identical
drainage volumes (Figure 5-7(c)).
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5.4 Discussion
The coupling between tissue mechanics and fluid flow has been described by
biphasic and poroelastic models which have been useful in elucidating biomechanical
functions of tissues such as bone and articular cartilage (Barry and Aldis 1990, Mow et al
1984, Grodzinsky 1983, Simon 1992) where deformation-induced fluid flow dominates
any other fluid transport mechanisms. In other tissues such as skin, the lymphatics may
play a more important role in governing fluid distribution. The aim of this chapter was to
evaluate the mechanical relationships among key variables which control interstitial-
lymphatic fluid balance (i.e. Figure 5-1) and utilize the mouse tail model to examine this
description. The model was based on the assumption that the balance between stress
(hydrostatic pressure), strain (hydration), and lymphatic drainage was governed by three
tissue parameters - effective tissue elasticity, hydraulic conductivity, and lymphatic
conductance - which were taken as effective or bulk-averaged constants within the injection
region. Although not without limitations, our model could predict the mechanical response
of a tissue to a controlled perturbation and yielded estimates of the effective tissue
parameters, albeit in swollen rather than normal states. Furthermore, the experimental data
confirmed that lymphatic drainage is an important determinant of interstitial fluid movement
in tissues such as skin and should be considered in modeling the mechanics of such
tissues. This is shown in Figure 5-3, where the stress distribution within a lymphatic-rich
tissue resulting from a continuous infusion is governed by the penetration length or ratio
between lymphatic and interstitial resistances. The characteristic time for the redistribution
of fluid pressure, Tp, following such a perturbation depends on tissue elasticity as well as
lymphatic drainage:
1 a 2
T - (5.26)P f3(2U + A,) K(2U + X)
Since the propagation of the pressure wave generated by an interstitial injection in a
poroelastic medium is determined by K(2+A), the effect of lymphatic drainage is a
reduction in the apparent propagation speed. This is shown in Figure 5-6, where the
parameter K(2M+A) is seen to affect the shape of pressure propagation (important at early
times) while a regulates the magnitude of the pressure profile (dominant at later times).
It should be emphasized that this characteristic time is for fluid or pressure
equilibration following the step increase in pressure at the tip. It does not describe the
uptake time introduced in Chapter 4, which characterized macromolecular transport. This
will be explored in Chapter 6. Aside from fluid pressure equilibration time, there exists a
characteristic time for injected fluid to saturate the injection length (T), which would be
equal to that for molecular transport if the molecules were much smaller than the
characteristic pore size within the interstitium. This is the time it would take for a packet of
fluid to travel the characteristic length a:
dx K *e-xla
dt E E
= t dx (5.27)
0o V pPo
Thus, the pressure distribution within a tissue following an interstitial injection can
be quantitatively described by the simplified theoretical framework presented. This allows a
new dimension to our understanding of lymphatic function and offers an insightful and
quantitative method for simultaneously examining three key constituents of interstitial-
lymphatic fluid balance in situ - swelling mechanics, interstitial transport, and lymphatic
drainage. Given that the response of the tissue is relatively sensitive to the controlling
parameters, this model can be used to evaluate different types of edema, examine the effects
of relevant drugs (such as those which alter microvascular permeability or the extracellular
matrix), or test clinical procedures such as tissue grafting on the various aspects of tissue
fluid balance, for example.
5.4.1 Hydraulic conductivity
The validity of the estimates for hydraulic conductivity and tissue elasticity can be
discussed on the basis of the vast amount of previous work to estimate these parameters.
These are summarized in a review (Levick 1987). Hydraulic conductivity has been
measured in many tissues in a variety of ways and, due to method and technique
differences, a broad range of values have been reported. Swabb et al reported a value of
5x10 -9 cm 2/sec/mm Hg for rat skin (Swabb et al 1974), and Bert and Reed found flow
conductivities in rat dermis between 3-8 x 10-9 cm2/sec/mm Hg (1995). The discrepancy of
over two orders of magnitude between their values and those presented here can be
attributed to the fact that these in vitro estimates resulted from pressure-flow measurements
across excised tissue. We estimated K in tail skin in situ and at maximal swelling. Since K
depends strongly on hydration (Levick 1987, Bert and Reed 1995, Bert 1970), both
because of frictional drag forces as well as electrical charge density (Aukland and Reed
1993), it is expected that a tissue undergoing compression would yield lower values of K
than if it were swollen by hydrostatic pressure instead. In fact, as early as 1966 it was
shown that changes in K of more than 5 orders of magnitude could result from various
swelling conditions (Guyton et al 1966). This is also seen from the confined compression
tests, in which K was estimated as 6 ± 2 x 10-7 cm 2/sec/mm Hg, or approximately half the
value found in situ. For the in situ model, hydration was accounted for and within the
infusion region, where pressure was higher than physiological values, the intrinsic K was
found to be approximately constant. This K represents an effective, bulk-averaged value
for normal tail skin which is acutely and temporarily swollen by an imposed IFP.
5.4.2 Tissue elasticity
Tissue elasticity is commonly reported as compliance, or the slope of IFV vs. IFP.
The first measurements were made by Guyton (1965), who showed the shape of the
compliance curves in general: linear at low pressures (in the range of negative to slightly
above normal), nearly infinite at intermediate pressures (approximately 5-7 mm Hg), and
linear again at even higher pressures. Since then, numerous measurements of tissue
compliance have verified this trend (although with lower pressure values using more
accurate techniques) and are summarized in a recent review (Aukland and Reed 1993). For
our purposes we assumed the compliance was linear within the characteristic length (region
of the imposed pressure profile) of the tail skin. In the limit of small strain, Equation 5.5
can be scaled to the approximation AIFP = (24u + A)AIFV. In this regard, the compliance
of the tail skin in the range of 10-50 mm Hg could be estimated as the inverse of elasticity,
or 0.91 ml/100 g wet tissue/mm Hg. Although the compliance of mouse tail skin has not
been reported to date, Aarli and Aukland estimated the compliance of rat tail skin between
0.1 and 0.34 ml/100 g wet tissue/mm Hg. It should be noted first that theirs was a radial
compliance rather than axial, so that hoop stress would tend to effectively decrease this net
radial compliance; second, that rat tail skin is much more "scaly" and thus less compliant
than that of the nude mouse; and finally, that they did not account for the bone volume in
their calculation of AIFV, which would result in an underestimation of compliance. Other
estimates of skin compliance include 5.4 ml/100 g wet tissue/mm Hg during dehydration of
rat skin (Wiig and Reed 1981), 7.5 ml/100 g wet tissue/mm Hg in hydration of dog skin
(Brace et al 1979), and 3.2 ml/100 g wet tissue/mm Hg in cat skin (Wiig and Reed 1985).
Discrepancies are most likely due to the method of measurement, location of skin and
species, and state of the animal or tissue (i.e. post mortem or in vitro).
Furthermore, there are documented differences between tissue elasticity measured
in situ with that measured in vitro. For example, the stress-strain relationships in skin were
crudely measured before and after a tattoo grafting operation and it was found that for all
levels of unidirectional tension, the modulus was lower in situ than in the excised specimen
(Kenedi et al 1965). These researchers also showed nonlinear stress-strain relationships
for human skin in uniaxial tension, whose slopes increase with tensile strain until the
failure point is reached. This is presumably due to the stretching of the randomly
intertwined collagen bundles. At low strains, the collagen fibers begin to straighten in the
direction of the load, and as strain increases, these fiber bundles become more oriented and
more closely packed (resulting in an increasing modulus) until the failure or breakage point
is reached (Markenscoff and Yannas 1979). This has also been shown histologically (Craik
and McNeil 1965). In light of this, we would expect low tensile strains to yield a smaller
elastic modulus than equivalent compressive strains, which would pack the matrix fibers
closer together and therefore resist deformation more. The fact that charged components of
the ECM are also concentrated during compression, increasing the Donnan forces within
the interstitium, would also contribute to this effect. Also, higher strains were used in the
confined compression tests than those which resulted from the interstitial infusion.
5.4.3 Net lymphatic conductance
Lymphatic conductance has been considered in this study as a lumped parameter,
combining the resistances to fluid drainage posed by the initial lymphatic structures with the
systemic drainage capacity rather than a true permeability of a lymphatic capillary. In
relation to interstitial resistance, this parameter is useful in understanding the overall tissue
fluid equilibrium, and as such, the few literature estimates of local (Starling) lymphatic
fluid conductance (Abernathy et al 1995, Hendriksen 1985) are not relevant for comparison
purposes. The lymphatic conductance presented here is meaningful in examinations of
different physiological and pathological conditions in the tail model, e.g. in lymphedema,
tissue grafting, or drug effects. These will be explored in Chapter 7.
5.4.4 Distribution of hydration and fluid velocity
From the stress-strain relationship of Equation 5.2, the distributions of fluid
velocity and strain or hydration can also be evaluated from the pressure measurements.
Starting with Darcy's Law (Equation 5.6),
v - = -K-
dt dx
At steady state, = 0 and P' = Po e -xa. Strain isdt
related to hydration by
Vo VT 1V-0
and since P*=(21+,)e, hydration is related to pressure by
P* + 0(2 +A )
0 P* + (2y. + A)
Therefore, the steady-state swelling distribution is
Po*e - x a + 0(2y g+ A)
Poe - x a + (2y + A)
and the steady-state bulk velocity profile is
K dP _ Po' lK e- xa(Poe - x1a + (2yi + A))
v(x) = -$s, 3x Poe - x/° + 0o(2/ + A)
(5.28)
(5.29)
(5.30)
(5.31)
5.4.5. Assumptions and limitations
The parameters were initially kept as constants because of the assumption that
within the characteristic length of the infusion, swelling was maximal and changes in the
parameters were small compared to their values. In this way they represented bulk-
averaged quantities in this region, where all of our measurements were made. The
assumption of constant K was discussed in Section 5.2.1. It is also possible that the tissue
fluid volume fraction, or state of hydration, can affect lymphatic uptake. Lymphatic
capillaries are thin-walled and usually without a basement membrane, consisting of a
monolayer of overlapping endothelial cells whose intercellular gaps comprise channels for
lymph formation. To preserve integrity, therefore, they rely on anchoring filaments which
secure the endothelium to structural components of the interstitial matrix (Leak 1976,
Castenholz et al 1991a, Gerli et al 1991, Aukland and Reed 1993); as the interstitium fills
with excess fluid, the matrix swells, exerting tension on the anchoring filaments which pull
open the pores of the lymphatic capillaries to effectively increase their permeability. This
concept has been supported by the observation that changes in IFV alone (without change
in IFP) cause changes in lymphatic drainage (Hogan and Unthank 1986, Aarli et al 1991 a).
In the analysis presented here, the parameters governing fluid distribution are considered
averaged over the entire pressure gradient imposed (again, where swelling is assumed
maximal), and small variations in lymphatic permeability due to changes in hydration
should be negligible compared to the overall average. Furthermore, it is assumed that the
applied pressure gradient is much larger than normal physiological pressure oscillations
(Aukland and Reed 1993, Bollinger 1993, Hogan and Unthank 1986, Zaugg-Vesti et al
1993) and thus dominates forces driving lymphatic uptake. In this case, the porosity or
permeability of the initial lymphatics would be maximal and thus constant throughout the
bulk of the applied pressure gradient (where most of the fluid uptake occurs). This
assumption is verified by the linear data shown in Figures 5-3 and 5-4.
5.5 Alternative methods
The experimental methods presented up to this point have sought to verify the
theoretical framework and yield estimates of three parameters which control the mechanical
aspects of tissue fluid balance. It would be desirable to utilize this model for parameter
approximations in various other states of tissue fluid balance, such as the effects of relevant
drugs, lymphedema, enhanced microvascular permeability, or alteration of the extracellular
matrix. The micropipette techniques presented here, however, are difficult and tedious,
causing obstacles for routine use. This section describes an alternative method for
estimating the parameters K and /3 using fluorescence microscopy rather than
micropipettes. Although it is an approximate method, based on measurements of
characteristic lengths rather than pressure profiles, it is much simpler experimentally and
still sensitive enough to measure gross changes in the parameters during lymphedema and
other conditions (which will be explored in Chapter 7).
5.5.1 Theory
According to Equation 5.20, the IFP profile at steady-state decays exponentially
with the ratio !K I /. This is also shown by the steady-state IFP measurements in Figure
5-3. For any given pressure P* , therefore, the relationship between the infusion pressure
Po and length L at which V- = (-K/e)VP* = KfKP*e- x/1 is given by
PL = -aInP= a(ln P - In P)
or
InP =- L + nP (5.32)
Theoretically, we could estimate the ratio cx by simply measuring a steady-state
"length" associated with a specific PL as a function of infusion pressure. We would define
the length L as that length in which P / Po is small enough for solute convection to be
negligible. The exact value of PL need not be defined as long as consistency is maintained
with each measurement and the times of measurement are not too long - i.e. when
molecular diffusion might affect the visible length. As we shall see, this is indeed feasible
and yields approximate values for c which are consistent with those found from IFP
profiles. First of all, the characteristic time for infused fluid to saturate this region is shown
by Equation 5.30 to be on the order of ,, or less than 14 minutes, according to the
parameter estimates from Table 5.1 (and assuming E is less than 1). Fluid is not visible,
however, but rather the fluorescently labeled molecules which convect with the fluid. The
characteristic time for solute transport in the tissue will depend on tissue-solute interactions,
such as size exclusion, but the characteristic length should be the same as that for fluid
transport if molecular diffusion is neglected4 .
5.5.2 Methods
To test this idea, five mice were infused (at constant pressure) with a solution
containing FITC-Dextran 2M (Sigma) according to the methods outlined in Chapter 3.
Infusion pressure was increased every 30 minutes from 45 to 60 cm water (33-44 mm Hg)
and images acquired with the Hamamatsu CCD camera for on-line analysis (again, refer to
Chapter 3 for details). Average pixel intensities were recorded for 10-20 vertical rectangles,
each spanning an axial length of 300 micrometers. Characteristic lengths were determined
by finding the steady-state "front" - i.e. the vertical rectangle which had the greatest
intensity change between its end intensities. This estimate was used rather than a mean
distance (i.e. Y = J Oxdx Odx, where 0 is the normalized intensity as defined in Equation
0 0
3.1) because of anticipated gradients in the concentration or intensity profiles within the
characteristic length. In other words, a mean distance would refer to the solute transport,
while the "front" would more accurately represent the characteristic length of the infusion
by ignoring solute concentration gradients within the injection region. These two distances
would only be equivalent if the solute can be approximated as a marker for fluid movement
(i.e. infinitesimally small compared to the dimensions of the extracellular matrix "pores"
and electrically neutral).
4 The diffusion coefficient of FITC-Dx 2M in water is on the order of 10-7 cm 2/s using FRAP (unpublished
data). Diffusion coefficients in tissue are about 3 times lower than those in water for molecules of this size
range (Berk et al, 1993). Therefore diffusion will be negligible compared to convection when x/v<<x 2/D.
From Equations 5.6 and 5.20, v = (-K/e)VP* = -KP e-x ia , and according to Table 5.1, f=-4x10 -5
s-'.mmHg-', K=1.5x10 -6 cm 2 S-1-mmHg 1', and a=0.2 cm. Thus for Po* =30 mmHg, molecular diffusion is
5.5.3 Results and implications
Figure 5-8 below shows a typical progression of the moving front resulting from an
infusion of FITC-Dx 2M (0.01 g/ml). As expected, the characteristic times required for the
establishment of the characteristic length (i.e. for fluid to saturate the infusion region) is on
the order of 10 minutes. Thus, a 30-minute period was allowed to confirm the estimation of
the characteristic length.
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Figure 5-8. Position of the "leading edge" of fluorescent solute, or "moving front", with
time. At each 30-minute interval, infusion pressure was increased step-wise by 5 cm water
(3.7 mm Hg) which is indicated by the vertical dotted lines. The establishment of
approximate steady-state conditions can be seen before each successive perturbation.
negligible compared to convection for distances less than 2 cm. This is well within the characteristic
infusion length of 2 mm and the region of measurements.
If this front length L is plotted against ln(Po*), then 1/a is the slope and ln(P) is
the intercept. This is shown below in Figure 5-9, using the data from Figure 5-8 and
assuming a baseline pressure of 9 mm Hg (see Table 5.1).
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Figure 5-9. Length of infusion, as measured by the saturation of the interstitium with
fluorescent tracer (FITC-Dx 2M), vs. In(P). As shown, this particular data yielded a slope
a of 2.8 mm.
This was performed in five mice, yielding an average value for a of 4.7 mm with a
standard deviation of 1.9 mm. Together with the pressure-flow measurements (Equation
5.21 and Figure 5-4), the parameters K and P can thus be easily estimated from a simple
two-hour experiment. From five experiments, these parameters were calculated to be 2 ± 1
x 10-6 cm 2.s-1mmHg-' (mean ± s.d.) for K and 7 ± 5 x 10-6 s-'.mmHg1' for P. This can be
compared to estimates from the more precise micropipette technique of 1.5 ± 0.4 x 10-6
cm 2.s-.mmHg-' and 4 ± 2 x 10-' s-'.mmHg-1 , respectively. Although this alternative
method results in approximate values of a (i.e. higher standard deviations than that
obtained with the micropipette measurements of the steady-state IFP profile), it is much
simpler and relevant for acquiring bulk estimates of the tissue parameters K and P for a
variety of conditions. The alternative method will therefore be used in Chapter 7, where
modifications in tissue fluid balance are investigated.
5.6 Conclusions
The model presented here provides an accurate description of convective interstitial-
lymphatic fluid movement and represents a valuable tool to estimate tissue and lymphatic
transport parameters in situ. Aside from interstitial fluid pressure, the model also describes
the distributions of fluid velocity, tissue dilatation, and stress. The good agreement
between the theory and experimental results, along with parameter estimations which are
within physiological ranges, support the validity of the model and its assumptions. To
study interstitial-lymphatic mechanics, however, more important than the actual values of
these parameters are their functional relationships which can be investigated only by
perturbing the system and measuring its transient and steady state responses. In this way,
the model can be used to study the mechanisms of pathological conditions such as edema.
Furthermore, this description of fluid transport provides the necessary foundation for
studying convective macromolecular transport.
Chapter 6
Convective interstitial-lymphatic solute
transport
6.1 Introduction
Useful and appropriate theoretical models require a careful balance between
simplicity and relevance. The model must be accurate in describing a particular
phenomenon while still maintaining the fundamental physics which govern the primary
level of the problem. It is especially a challenge to model physiological systems because the
underlying or microscale processes are usually poorly understood.
The goal in this section was to translate observations of convective phenomena into
estimations of bulk transport hindrances in situ. In Chapter 4, fluorescently labeled solute
was used to indicate fluid transport within the lymphatic vessels. Here, the focus is shifted
from transport of the fluid within the vessels to the interstitial transport of the solute.
Interstitial solute movement can be observed by fluorescence intensity measurements near
the injection. If the intensity is linearly proportional to concentration, the normalized
intensity profiles would be equivalent to interstitial solute concentration profiles. Typical
profiles which motivated this work are shown in Figure 6-1. In solution, these intensities
were well within the linear intensity-concentration range but could not be calibrated because
it was not possible to measure tissue concentrations.
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Figure 6-1. Spatial profiles of FITC-Dextran 2M at 2.5, 4.2, 5, 8, and 10 minutes
following injection.
Direct observation suggests that different molecules convect through tissue at
different rates and in different ways. For example, larger molecules may convect faster and
with a steeper concentration gradient than smaller molecules. Along with fluid convection,
various factors were considered which could give rise to differences in spatial and temporal
concentration profiles. For example, size partitioning would result in larger available
volume fractions for smaller molecules, yielding slower net velocities and increased
dispersivity.
It should be emphasized that the goal here was not to examine the microscopic
interactions between the solute and the tissue which give rise to interstitial or lymphatic
transport behavior but simply to measure or characterize their macroscopic effects. This
would provide not only a much needed quantitative in situ model for convective transport
of macromolecules, but also a tool for exploring and optimizing drug delivery both for
targeting the lymph nodes as well as any drugs which are injected interstitially, such as
vaccines or intratumoral infusions.
6.2 Background
There are several ways to describe the distinguishing features of the interstitial
concentration profiles exemplified in Figure 6-1, depending on the information desired.
The following sections will discuss some of the theoretical considerations, their
implications, and their relevance in characterizing key aspects of convective transport of
macromolecules following an interstitial injection.
The general problem in consideration arose from the RTD studies of Chapter 4. It
was observed that although the net velocity in the superficial network was independent of
injection pressure (Figure 4-2), there was a characteristic uptake time which did depend on
the injection pressure. This was seen by extrapolating the relationship between distance and
mean residence time (MRT), which was measured within the lymphatic capillaries, to an
arbitrary distance close to the injection. At higher pressures, this characteristic time was
shorter and it took less time for the lymphatic network to become stained.
First, then, the relationship between injection pressure and a vaguely-defined
characteristic uptake time T was examined to obtain a zero-order understanding of the
phenomenon. Following the procedures of Section 4.3.1, T was calculated as the
extrapolation of x vs. MRT (downstream in the lymphatic capillary network) to x=O
(defined at the needle tip). This was estimated for different injection pressures in four
different mice, and the results are shown in Figure 6-2. This verified that the characteristic
uptake time was indeed inversely proportional to the injection pressure. The next step was
to determine the key determinants of macromolecular transport and uptake according to
properties of the specific solute molecule itself, so that the model could fulfill its potential
as a unique and powerful tool for observing and measuring convective macromolecular
transport in vivo.
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Figure 6-2. Relationship between injection pressure and "characteristic uptake time", which
was taken from plots of intralymphatic MRT vs. distance (see Figure 4-2) as the intercept
or MRT at x=O.
6.3 Solute convection
Considering the most general case, solute convecting through tissue may undergo
dispersion (with molecular and convective parts), convection, disappearance into the
lymphatics, and adsorption onto the extracellular matrix or cells. The corresponding
coefficients for each of these mechanisms are not constant (the fluid velocity and pressure
profiles, on which they all depend, are exponential functions of distance), and thus a
balance which includes all mechanisms may be overly complex compared to the
experimental data to which it is applied. The goal here was to simply describe macroscopic
concentration profiles which could be measured in the mouse tail.
At first, the concentration profiles were modeled using convective transport
equations where dispersive effects were considered small compared to convection. A drag
coefficient ' was utilized as a phenomenological coefficient to describe a bulk hindrance to
interstitial convective transport ( = 1 implies no hindrance). A reflection coefficient UL was
defined in a similar way for bulk hindrance to lymphatic uptake (i.e. =0O when solute
moves freely into the lymphatics with no translymphatic concentration difference, and L= 1
when the lymphatics are impermeable to the solute):
dC CX + +V ( C+ J v(1- )C-- = 0 (6.1)
where C is the total tissue (macroscale) concentration, vf is the bulk fluid velocity vector, e
is the fluid volume fraction, and J, is the lymphatic drainage term (volume of fluid drained
per tissue volume per time) as defined in Equation 5.12 (Jr=#P*). In the one-dimensional
system of Chapter 5, Vblk = J3/KP* where P = effective lymphatic conductance (s-'1 mm
Hg-'), K = effective hydraulic conductivity (cm 2.s-.mmHg-'), and P* is the IFP in the
tissue above baseline (mmHg).
If the pressure profile is assumed to be at steady state (i.e. P* = Pe -i, where
x = x f/ K) and we only consider one dimensional flow, then Equation 6.1 simplifies to:
dC C
+ e- + kle-xC = 0 (6.2)
where t' = PlPot and
representing an effective decay rate coefficient.
Appropriate boundary conditions are those of a semi-infinite medium with zero
initial concentration and constant flux at the boundary:
[f Cl=o = Qinj Cinf
area (6.3a)
LC(x, 0) = 0
where Cinj = infusate concentration, area = cross-sectional area of dermal/subcutaneous
tissue tail (see Section 3.6 and Figures 3-3 and 3-9), and Qif = infusion flow rate. The
latter was discussed in Chapter 5 and evaluated at steady state in Equation 5.21:
Qinf = Qss = area PKP*;
therefore,
C(0,t) = fin (6.3b)
Transforming into Laplace space, with C(k, s)= L[C(i, i)], Equation 6.2 becomes
e X +(ke- +s)= 0
with a transformed boundary condition of
C(0, s) = iff
This is easily solved:
C IS= 'n exp (-(kix + s(e -1)
s( (
and inverted to give
C= C exp(- x ht (ei 1 (6.4)
where h is the Heaviside step function. Upon examination, Equation 6.4 can account for
spatial concentration decay within the interstitium but not their transient developments. This
is expected, since the only time effect arises from the fluid movement (convection) and
therefore the transient behavior of solute movement predicted by such a model is simply a
step function. In other words, the concentration at any distance is instantly fixed as soon as
the injected fluid has traveled that distance, and thus the last term in Equation 6.4 represents
the time for fluid to travel a distance x at steady state.
It can also be readily seen from Equation 6.4 that a characteristic time associated
with solute movement is linearly proportional to the inverse of u ,, which is consistent with
the original findings of Chapter 4 (see Figure 6-2), since u1 = fPP. Graphical
representations of Equation 6.4 are shown in Figures 6-3 (a)-(b). The major limitation of
this approach was, of course, that the spatial profiles did indeed show a strong transient
development as shown by the different curves in Figure 6-1.
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Figure 6-3 Left (a): Concentration vs. time
for several distances as predicted by Eq.
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6.4 Convection and adsorption of solute
To phenomenologically describe the transient behavior of solute convection, a new
model was considered using concepts of adsorption rather than convective drag:
dC (1-o)n
- + V -(i C) + Jv C + (1- E) -= 0 (6.5)
dt E dt
dn
where (I-e) is the solid fraction and - represents the net rate of solute "adsorption" to the
solid or immobile fluid phases of the tissue (n [=] moles per volume solid). Such a model
is commonly used to describe adsorption chromatography (Aris and Amundson, 1973,
Watson and Jones 1984, DeSmedt and Wierenga 1979).
If linear adsorption is assumed, the adsorbed concentration can be expressed as:
dn
= Vy(KC - n) (6.6)dt
where c is a partition coefficient and Vis the linear adsorption coefficient [s'].
Consider some limiting cases: (1) Vy goes to infinity (instantaneous binding), (2) K
goes to zero (no binding), and (3) short times where iC>>n. Case (2) is equivalent to
Equation 6.1, and so we will not consider that again here. Case (1) would imply that solute
cannot move through the tissue at all because it adsorbs immediately. Case (3), however, is
experimentally close to what we would expect from the measurements shown in Figure 6-
1. It only neglects saturation effects and would thus be valid only for short times and/or
small concentrations compared to "binding sites". Because this model is applied here to
phenomenologically describe solute dispersion and buildup, saturation-type effects will be
neglected.
If C>>n, the binding term defined in Eq. 6.6 becomes VrIC. In this way the
parameters V and c are indistinguishable in terms of experimental measurements. Therefore
they are lumped into a new parameter here which will be called y to represent the
(insaturable) affinity for adsorption (incorporating the solid fraction 1-e as well; i.e.
7-Y-(I-E)). Then,
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dC
-+ V .(f C)
dt + ( 1) + Y)
C = O.
Once again assuming steady-state fluid velocity, this can be written as
where X = x4 /K and t = PP as before, k2 = ,
ppP*
and k3 ((1-aL)
E
The constant-flux boundary condition is now C(O, ) = Co = ECi.f, since any tissue "drag"
or hindrance to convection is now modeled as adsorption/desorption phenomena.
In Laplace space, Equation 6.8 becomes:
e-d + (s + k + k3 e - )C = 0
whose solution has a similar form to the previous case:
S= exp(k2(1s p(( -e) -k 3X +S(1- e)
Inverted, this yields a concentration profile
C= ECif exp((k 2(1 -e) - k3 ))h - (e - )) (6.9)
which still has a step dependence on time but whose spatial profiles have a bifunctional
dependence on distance. Spatial profiles are shown below along with their dependence on
the parameters y, E, and aL.
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(6.7)
dC dC
+e- + (k2 +k3e-x)C = 0, (6.8)
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Figure 6-4. Spatial profiles described by Equation 6.9 using the same parameter values as
before (see Figure 6-3 legend). Unless noted, values for e, oL, and y were taken as 0.5,
0.1, and 0.002 s-1, respectively.
Therefore this model could account for the spatial dispersion of Figure 6-1, but not a
transient dispersion. In other words, it attributes spatial concentration gradients to
adsorption which is assumed insaturable. To validate the condition of insaturability, short
observation times were required (i.e. the "plateau" seen in later times in Figure 6-1 could
not be accounted for by this model).
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6.5 Dispersive effects
Although a simple macroscale model was desired to highlight the dominant
principles which governed solute transport through skin, it was clear that a second-order
term - dispersivity - would be required to describe transient behavior of solute movement.
Because the velocity field decayed within that characteristic region, a dispersivity which
depended on velocity was necessary.
6.5.1 General theory
In the following analysis, the dermal or subcutaneous tissue of the tail is treated as a
one-dimensional, semi-infinite, homogeneous porous media whose fluid balance resulting
from an interstitial injection is described in Chapter 5. Solute which moves through the
interstitium may have a different volume fraction (0) in which to travel than that of the
mobile bulk fluid (e) due to partitioning. Furthermore, dispersive effects may arise from a
number of factors including shape, charge, and molecular diffusivity of the solute as well
as variations in the local (microscale) fluid velocity.
Caution must be exercised in defining an appropriate conservation equation for
convective-dispersive solute transport through porous media. A phenomenological
convective-diffusive representation, which is analogous to local or exact behavior in a well-
defined system (i.e. Taylor 1953), can be expressed on a macroscopic scale by careful
definition of the macroscopic variables'. This was elegantly shown by Brenner (1980)
using a method of moments. Here, lymphatic drainage is included as a sink term, R,, in
which solute 'disappears' or convects into the lymphatics along with the draining fluid. On
a macroscopic scale, L (length scale of observation) >> 1 (length scale of a hypothetical
pore), and the bulk (measurable) solute concentration is governed by the following
macroscale relation:
+ V J +R, =0 (6.10)
'A bulk-averaged quantity P is defined here as P = PdV, where P is the local variable and V, is
Vo
the total tissue unit volume.
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where C is the average (measurable) solute concentration in the tissue, R represents
solute drainage by the lymphatics, and J is the net solute flux. This is given as
J = U*C -D .VC (6.11)
where U* and D are the macroscale or apparent solute velocity vector and dispersion
dyadic, respectively. They represent macroscopic phenomenological parameters which
depend on a number of possible factors including the underlying (microscale) structure of
the tissue and solute-tissue interactions.
6.5.2. Constitutive equations and variable definitions
It is desired to apply Equations 6.10 and 6.11 to the solute concentration profiles
exemplified in Figure 6-1 (i.e. those resulting from an interstitial injection into the tail skin)
in order to estimate bulk-average transport parameters. We will first focus on defining the
variables for the tail injection system to determine a specific macrotransport conservation
equation, then discuss assumptions and limiting cases in which the key parameters may be
evaluated.
Combining Equations 6.10 and 6.11 for a one-dimensional system and omitting the
overbars for simplicity, we have
X + d (U' C) - D + Rv =0 (6.12)
dt x x x )
with the boundary and initial conditions of the system either as constant surface
concentration:
C(x,0) =0
C(O,t) = Co , (6.13a)
dC =0
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where Co=C (e+(1-e)c), or with constant surface flux:
C(x, 0) = 0
-D* dC +U*C Qinfnf (6.13b)
-x=o A
dC =0
dx I,,,
For simplicity, the first condition (constant concentration at x=0) will be considered in this
section.
Effective solute velocity U*
A partitioning model is assumed to describe the mean solute velocity U*. In this
case, U*differs from the average net fluid velocity v* (i.e. the Darcy velocity, or flow rate
per total tissue area) by the porosity E and a partition coefficient K (Brenner 1980)
according to:
U* = (6.14)
E + (1- e)KC
Partitioning is somewhat ambiguously defined here, since the interstitial space is more like
a polymer gel than a packed bed of porous beads for which this was intended. In the
present case, the porosity represents the mobile fluid volume fraction in which all solute
molecules can move, and the solid or partitioning phase represents other "pores" in the
interstitium into which smaller molecules can diffuse. Then, the larger particles will have
higher macroscale velocities than the smaller particles, a phenomenon also known as size-
exclusion chromatography. The upper limit of mean solute velocity is reached when c-0;
i.e. when the solute has no partitioning into the non-mobile phase. In this case U* will be
equal to the true mean interstitial fluid velocity v *. Because the parameters e and K cannot
be distinguished experimentally, the symbol 0 will be used to represent the available
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volume fraction for a given molecule; i.e. E = + (1-E)c. Therefore, (1-0) is the excluded
volume fraction and > E accordingly.
In Chapter 5, it was established that at steady state, the Darcy-scale axial fluid
velocity (not the pore fluid velocity vpore of Equation 5.6 but instead VDarcy=EVpore) decayed
exponentially with distance:
v,, = KPoe - x I'  (6.15)
This decay of fluid velocity is essential to the analysis. The concentration profiles develop
almost entirely within the characteristic injection length, yielding a variable dispersivity
which should be governed by the fluid velocity at relatively small x and by molecular
diffusion when x>>o. We cannot assume constant velocity even for small ranges of x
close to the injection, because the profiles at any distance are governed by their dispersion
history. Also, this fluid velocity affects the drainage and convective terms as well as the
convective part of the dispersion term in Equation 6.12, since dispersivity is presumably a
function of velocity.
It was shown in Section 5.4 that the characteristic time for fluid pressure to reach
the steady state following injection, TP, was on the order of (fl(2I+.)).1, or roughly 10
minutes. By a simple scaling analysis of Equation 6.13, the characteristic time for the
solute convection (Tp) is U*-', or roughly O(efPoP.)'. Then the ratio T/T p - 0(2y+A)/eP o
will be assumed to be much greater than 1 for the experiments described and is verified by
simultaneous measurements of IFP and solute movement at 1 mm from the injection,
shown in Figure 6-5 below. This assumption allows us to consider the steady-state fluid
velocity in observing solute concentration profiles, which, from Equation 6.14, leads to a
mean solute velocity of
U* -- KP e - x lau= e
0 (6.16)
= -xula
= Uoe
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Therefore, a steady-state fluid velocity can be assumed in modeling solute convection.
Furthermore, by simply comparing mean solute velocities in the tail skin tissue, we can
estimate the ratio dF/.
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Figure 6-5. Transient development of interstitial fluid pressure (IFP) and solute
concentration at a point approximately 3 mm from infusion.
Effective dispersivity
Dispersivity in porous media such as tissue is a phenomenological occurrence. It
can arise from a number of factors including interactions between the solute and the
interstitium (mechanical as well as electrical or chemical), immobile fluid and stagnant flow
regions, and molecular diffusion. If a dominating mechanism can be identified and
accurately described, then the dispersive term may not be needed. Such is the case for
adsorption chromatography, which is often treated as we have above in Section 6.4.
When the interactions are more complex and when several mechanisms come into
play, a generic dispersivity term serves the purpose of describing bulk macroscopic effects.
However, because of the nature of its bulk definition, this term is sensitive to its
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circumstances. For example, for flow in streams or long packed beds where x>>L,
dispersivity may increase asymptotically according to distance (Bear 1972):
D* = aL( -(1-e-bx/L)+DM (6.17)
where a is the slope of x vs. D at x=0, b is a constant (<1), L is the characteristic length,
and D' is the molecular diffusivity. Furthermore, when x/L < 200, the exponential model
for dispersivity predicts concentration profiles nearly equivalent to those predicted from a
linear dispersion model (Yates 1992, Yates 1990):
D* = a2 -- + DM. (6.18)
eL
A number of other relationships between dispersivity and space, time, or velocity have also
been postulated (Logan 1996, Rubinstein and Mauri 1986, Auriault and Adler 1995, Basha
and El-Habel 1993).
For the mouse tail model, solute dispersion is observed for relatively short
distances and short times. Since the characteristic length for velocity decay is on the order
of our observation length scale, it would seem appropriate to put the primary dependence of
D* on fluid velocity. Therefore, a linear relationship will be assumed:
D* = Dc + DM = Avf + DM (6.19)
It will be further assumed that in the region of measurement, convective effects on
dispersion dominate diffusive effects. Since the solute molecules in question are very large
(2 to 2,000 kDa), this assumption infers that the Peclet number will be large within the
region of measurement. Although this cannot be verified yet since there is no basis for
estimating the convective dispersion parameter A, it can be confirmed a posteriori.
Therefore,
D* = Avf = A /KP *e- x1a
=Doe-xIa . (6.20)
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Lymphatic drainage
Finally, the lymphatic drainage term remains to be defined. Again assuming
convection-dominated solute drainage, a first-order type decay is expected according to
Rk = JC (1I- aL) (6.21)
where J, is the fluid drainage into the lymphatics given by Eq. 5.12. At steady-state fluid
pressure, this becomes
R = 1fPoe-xla(1- OL) C
= ke-x IaC. (6.22)
6.5.3 Conservation Equation
Combining Equations 6.12, 6.16, 6.20, and 6.22, the conservation equation for
one-dimensional, convective-dispersive solute transport with lymphatic drainage becomes:
dC -D2C X C(D od dC + kdex D + +Uo -- + ko
at 2 a d o
Using the dimensionless variables x = x and t"= t,
a
e8C d 2C dC
e Do + Uo + kC= 0
-!OC = 0.
this can be written as
(6.23)
where Do, uo, and ko are given by
Do=A
a e
uO = A +1 = D +1,
aE
and ko = 0(1-2 -1,82
representing the bulk-effective equivalents of the parameters (diffusivity, mean solute
velocity, and first-order decay constant, respectively). Note that the parameters 0 and oL are
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always seen in conjunction with E and so only the ratios Ole and (1-a)/E are important in
determining solute transport behavior.
Simulations
Numerical solutions to Equation 6.23 with boundary conditions of constant surface
concentration (Equation 6.13a) were generated to investigate the effects that each solute
transport parameter (A, le, and (1-Qr)/E) had on the bulk concentration profiles. These
were performed using previously written code (Baxter, 1990) and are shown below in
Figures 6-6 (a)-(g).
-
0
0cO
C,
0Ca)O
0
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
0 0.5 1 1.5 2 2.5 3 3.5 4
Distance (mm)
Figure 6-6. Graphical representations of Equation 6.23. (a) Baseline parameter values of
A=1.0 mm, /e-=2, and (1-qL)/e =3.3. Fluid transport parameters /f and K were assumed to
be 4x10 5- s-'.mmHg -' and 1.5x10 -4 mm2.s- .mmHg-', respectively, according to Table 5.1.
Thus, Do=1.03, u*=2.03, and ko=5.67. Concentration is normalized to the constant
surface boundary condition; i.e. C,,or,=C/Co=C/(C,,i).
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Figure 6-6 (b) Parameter values are the same as those given in Fig. 6-6(a) except A is
decreased to a value of 0.1 mm. Thus, D =0.103, u =1.103, and ko=5.67.
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Figure 6-6 (c) Parameter values are
increased to a value of 5 mm. Thus,
the same as those given in Fig. 6-6 (a) except A is
Do=5.165, u*=6.165, and ko=5.67
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Figure 6-6 (d) Parameter values are the same as those given in Fig. 6-6(a) except O/e is
increased to a value of 2.67. Thus, D =1.377, u*=2.377, and k*=8.89
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Figure 6-6 (e) Parameter values are the same as those given in Fig. 6-6(a) except I/e is
decreased to a value of 1.0. Thus, Do=0.5165, u*=1.5165, and ko=2.33
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Figure 6-6 (f) Parameter values are the same as those given in Fig. 6-6(a) except oL is
increased to a value of 0.1. Thus, D =1.03, u*=2.03, and k =5.00
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Figure 6-6 (g) Parameter values are the same as those given in Fig. 6-6(a) except ("L is
increased to a value of 0.3. Thus, D,=1.03, uo=2.03, and ko=3.67.
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Figures 6-6 (a)-(g) reveal the implications of the convective-dispersive model
described by Equation 6.23. Figure 6-6(a) is regarded as the "baseline" plot while (b)-(g)
show perturbations of each parameter about this baseline. The most prominent feature of
the plots is the rise in normalized concentration (C,,,,= C/(Ci, )) to values greater than one
at longer times. This effect is exaggerated by increasing A or cL or decreasing the ratio O/e.
The physical meaning of this rise and subsequent decline, or crest, in the solute
concentration profiles is not intuitively obvious.
A critical consideration of the theoretical model is the fact that the boundary
condition for large distances (x approaching infinity) given in Equation 6.13 only applies to
Equation 6.23 for relatively short times. Since the velocity decays exponentially, it never
reaches zero exactly and therefore the solute can continue to progress beyond the
characteristic injection length, although at infinitely slow rates. The evaluation of Equation
6.23 at steady state reveals a linear, homogeneous second-order ordinary differential
equation with constant coefficients:
d2 C dC
Do &-2 UO koC = 0. (6.24)
Since Do, u*, and ko are all positive numbers, a general steady-state solution is given by
Cs = blemx + b2em2x
where m, and m2 are
mm 2 Do* + uo2 +U 4koD
If we impose the conditions of Equation 6.13, then b, must be zero to satisfy the infinity
condition, leaving a simple exponential decay to describe the spatial profile of the solute (b2
is then O-C,,). This is not consistent with the curves in Figure 6-6, however, which show
increases in solute concentration at long times which peak before decaying exponentially to
zero.
The reason for this discrepancy is that a steady-state solution in solute concentration
cannot exist in a semi-infinite medium. The exponential decay of fluid velocity implies a
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corresponding exponential decay in solute velocity, so that solute continuously travels more
and more slowly at larger and larger distances. This concept helps to explain the crests in
the long-time solute concentration profiles shown in Figures 6-6 (a), (c), (d), (f), and (g).
If we examine the roots m, and m2 for each of the cases in Figure 6-6, patterns emerge
which correlate with the graphical features; these are summarized in Table 6.1 and
illustrated in Figure 6-7 which shows the profiles of Figures 6-6 at one hour. In particular,
it is shown that m, and m2 are greatly increased in magnitude when A is decreased to 0.1
mm, and conversely, greatly decreased when A is increased to a value of 5 mm. These
correspond to the most extreme decrease and increase, respectively, in the characteristic
humps of Figure 6-7, indicating that the higher the dispersivity coefficient, the greater the
effect of apparent accumulation (i.e. the rise and subsequent decline in concentration). This
is even more evident when we compare the mean convective solute velocity with the mean
dispersivity. This ratio can be regarded as a dispersive Peclet number, Pe = VoE8/ aor
Avo /a 2
. When Pe > 1, convection dominates dispersion. This is shown in Fig. 6.6 (b) and
AO
(e), which do not show characteristic humps. The humps are most exaggerated in cases (c)
and (d), where Pe < 1 and thus dispersive effects are greater than convective ones. Again,
it is emphasized that this is a direct consequence of the assumption of semi-infinite media
complicated by the exponential decay in velocity.
Therefore we can conclude that this effect is due to the choice of values for A in the
simulations relative to the ratio /e. When the dispersive Peclet number is less than one,
dispersive effects dominate and solute disperses or "builds up" at a greater rate than it
convects axially. Upon examination of our experimental data (as we shall later see), this
ratio is most likely larger than 1 so that convective forces dominate and no accumulation is
seen.
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case A (mm) q E q Do* Uo* ko* m2 m2 Pe
(a) 1.0 0.6 0.3 0 1.05 2.05 5.7 3.5 -1.55 1
(b) 0.1 0.6 0.3 0 0.105 1.1 5.7 14.3 -3.80 10
(c) 5.0 0.6 0.3 0 5.26 6.3 5.7 1.8 -0.6 0.2
(d) 1.0 0.8 0.3 0 1.4 2.4 7.9 3.4 -1.65 0.75
(e) 1.0 0.3 0.3 0 0.526 1.5 2.33 4.0 -1.1 2
(f) 1.0 0.6 0.3 0.1 1.05 2.05 7.4 3.8 -1.86 1
(g) 1.0 0.6 0.3 0.3 1.05 2.05 3.7 3.1 -1.13 1
Table 6.1. Summary of the coefficients used for Figures 6-6(a)-(g) with corresponding
effective parameter values and implications for fast times. Pe refers to the ratio atdA, or
the dispersive Peclet number, to which reference was made in the preceding text.
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Figure 6-7. Spatial profiles of each case shown in Figures 6-6 (a)-(g)
hour).
at long times (one
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Therefore, dispersivity acts in this model to extend the characteristic length of the
infusion region as well as to cause buildup within the convective region. Solute partitioning
dictates the magnitude of measurable concentration and the apparent (effective) solute
velocity, as well as affects buildup within the convective region, but does not affect the
apparent characteristic length for solute transport. Finally, lymphatic reflection coefficient
has the least effect on the solute transport profiles, perturbing the shape slightly (increasing
the buildup with increasing resistance, as would be expected) but not affecting the apparent
solute velocity or apparent characteristic length.
6.6 Experimental data
The first approach was to inject a fluorescently labeled solution of a particular
macromolecule, measure its intensity profiles over time, and fit these profiles to one of the
characterization methods presented in Sections 6.3-6.5. However, the experimental
variation proved to be greater than any measurable differences in solute concentration
profiles, and thus differences in transport behavior among different types of solute
molecules could not be evaluated.
To avoid ambiguity with fluid flow profiles and experimental variation, a second
approach was designed using a coinjection of two solutes, each labeled with a different
fluorophore. In this way their transport characteristics could be directly compared because
they were convecting with the same fluid flow parameters and relative to the same infusion
conditions in the same tissue. For each experiment, one solute was always used for
consistency and represented a standard to which the others could be compared. This
standard was chosen as a small, neutral molecule: dextran of molecular weight 3 kDa
labeled with Texas Red (TR-Dx 3K). It was coinjected with anionic FITC-Dx 3K, FITC-
Dx 71K, FITC-BSA (i.e. bovine serum albumin, which also has a molecular weight of
approximately 73 kDa but is globular in shape rather than linear like dextran), or FITC-Dx
2M. Therefore 'green' always denoted the experimental solute while 'red' denoted the low
molecular weight standard.
A typical spatial profile following a coinjection of FITC-Dx 2M and TR-Dx 3K is
shown in Figure 6-8. This profile was taken at 10 minutes from the start of the injection.
Distinguishing features include the short-distance plateau, lower apparent dispersivity, and
faster apparent propagation of the larger solute. This again suggests that excluded volume
plays a major role in determining the spatial profiles - a smaller 0 would result in faster
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apparent velocity and smaller C,is,,/Cflui d (which is the definition of relative intensity in
Figure 6-8). Complete data for each experiment are given in Appendix C.
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Figure 6-8. Solute concentration profiles for two coinjected molecules at 10
I- Ibkgd
Intensity was normalized as 0 = , where I was the measured intensity,
max - bkgd
minutes.
Ibkgd was
the pre-infusion or background intensity, and I. was the maximum intensity measured in
the tissue (taken as the limit of intensity in smaller and smaller sampling region).
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6.7 Analysis and discussion
6.7.1 Net solute velocity
It is appropriate to first evaluate the apparent solute velocity profiles to estimate the
relative 0 for each solute pair, since this is readily achieved. The fluid transport parameters
K and P can be estimated by measuring the dependencies of flow and characteristic length
on infusion pressure as described in Chapter 5. Or, the averages calculated in Table 5.1 can
be used; these were 0.009 mm 2-min-'.mm Hg-' for K and 0.0024 (min-mm Hg) -1 for P,
respectively, in the range of infusion pressure between 33 and 44 mm Hg (24-35 mm Hg
above baseline IFP).
Next, the net velocity of the solute can be measured relative to that of the standard
(TR-Dx 3K). Consider U* = , where T represents the mean residence time or the
concentration-weighted average time for the solute to travel a distance x. This can be
determined by the RTD method described in Chapter 4:
f Otdt
0
f dt
0
Since
U* = Uoe-x a
x =a ln(- UO + 1 (6.25)
Therefore by comparing t(x) for different solutes, U0 and thus 0 (=e+(1-E)ic) can be
estimated. This still does not reveal the partition coefficient, but by examining the behavior
of 0 for larger and larger molecules, the lower limit should provide an estimate for e. That
is, if the larger molecule, Dx 2M, is assumed to have negligible partitioning in the solid or
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immobile fluid phase, then e2M=E and the partition coefficient for Dx 3K (IC3K) can be
estimated from the measured ratio 2 k 3K by:
3 K =e(1- -2M/03K)
32M/3K(1 - E)
(6.26)
where e is estimated as the fraction e = tissue
6fluid
Cu
Cfluid
of the large solute molecule.
To show the effectiveness of this method, the mean solute velocity analysis of the
data from Figure 6-8 is shown in Figure 6-9. This particular experiment yielded a ratio
2A/ 3K = 0.58. A summary of all experiments is provided in Table 6.2.
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Figure 6-9. Mean distance or length of solute transport vs.
Dx 3K.
time for FITC-Dx 2M and TR-
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C,
Solute coinjected with Average volume fraction ratio
TR-Dextran 3K (standard) (Osolut/standard)
FITC-Dextran 3K (-) 0.89 ± 0.11
FITC-Dextran 71K 0.69 ± 0.08
FITC-BSA 0.64 ± 0.06
FITC-Dextran 2M 0.59 ± 0.09
Table 6.2 Average solute volume fraction relative to that of the standard for four different
macromolecules. The molecular weight of BSA is approximately 69K, but unlike dextran
of the same molecular weight, it is globular in form.
From Table 6.2, three key generalizations are proposed. First, negative charge may
decrease the effective partitioning of the solute. This is expected since the extracellular
matrix of skin has a significant percentage of glycosaminoglycans (Aukland and Reed
1993), which contain a high density of negative charge. Therefore we would assume the
net effect of a charged matrix on same-charge solute transport would be one of volume
exclusion.
Second, there may be reptation effects seen when comparing two molecules of the
same size but different shape. Dextran 71K is a linear molecule while BSA (-69K) has a
globular form. The BSA shows less effective partitioning, which may suggest that the
linear molecule can reptate into spaces which exclude the apparently larger albumin
molecule. However, it should be noted that the albumin has a slightly negative charge at
physiological pH, which may contribute to the decreased partitioning as well.
Finally, we see a definitive size exclusion effect by comparing FITC-Dx of
molecular weights 3K, 71K, and 2M. There is not a linear relationship between molecular
weight and 4. Larger particles - latex microspheres of 100 nm or larger - showed no
mobility within the interstitium following injection, so FITC-Dx 2M was taken as an upper
limit of solute size. From this it might be implied that the volume fraction 4 for FITC-Dx
2M is approximately equal to the mobile fluid volume fraction E, and thus a partitioning
coefficient for each molecule can be estimated by Equation 6.26.
To gain further insight into the problem using the simulated data, the net solute
velocity implied by each of the cases presented in Figures 6-6 were evaluated according to
the simulated data using the same methods. These are shown in Figure 6-10.
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Figure 6-10. Mean solute transport profiles for each of the cases in Figure 6-6.
As expected, the dispersivity strongly affects the apparent solute velocity. In the theoretical
analysis, the parameters A and r'e were considered independent. However, it makes sense
intuitively that the dispersivity itself would most likely be determined by the volume
fraction ratio be. This is supported by the simulations shown in Figs. 6.6. Therefore,
these data imply that the excluded volume effect is the most important factor in determining
solute transport behavior is the excluded volume effect.
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6.7.2 Spatial profiles
The spatial profiles from the coinjection data can also be analyzed according to the
theoretical developments in Section 6.4. If resistance to solute transport is modeled as an
insaturable adsorption phenomenon, the solute concentration profiles (see Appendix C) can
be evaluated to yield relative estimates of the effective adsorption rate coefficient (y) and
lymphatic reflection coefficient (aL). Upon fitting the curves in Appendix C to Equation
6.8, which are summarized in Table 6.3, it can be seen that the adsorption model is
adequate for characterizing differences due to size in solute transport behavior for relatively
short times. In other words, the larger the particle, the less interaction ("adsorption") with
the interstitial matrix. However, there seems to be an opposite trend (more solute-matrix
interaction) with negatively charged particles as compared to the size-exclusion phenomena
described in Section 6.5. This is most likely due to the decreased sensitivity of the methods
(i.e. the ratio for FITC-Dx 3K is actually close to 1), which is shown by the large standard
deviations in all parameter value estimates.
Solute coinjected with TR-Dextran 3K Average ratio y Average ratio k3 (solute/std)(standard) (YsoluteYstandard) k 3  (1- ) 1
FITC-Dextran 3K (-) 1.3 ± 0.2 1.6 ± 1.6
FITC-Dextran 71K 0.79 ± 0.02 1.0 ± 0.3
FITC-BSA 1.1 + 0.09 0.8 ± 0.2
FITC-Dextran 2M 0.58 ± 0.09 0.6 ± 0.4
Table 6.3. Data analysis according to the adsorption model presented in Section 6.4.
Of the k3 values, only that for FITC-Dx 2M was significantly different from 1 (p<0.05),
indicating little differences in lymphatic reflection coefficients among the various solute
molecules. This could be due either to the possibility that the lymphatics pose very little
resistance to solute transport compared to the interstitium, or to poor sensitivity of the
concentration profiles on lymphatic reflection coefficient. Most likely it is the latter; Figure
6-4 shows that when aL is increased from 0.1 to 0.5, very little effect is seen on the
resulting spatial concentration profile.
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6.8 Conclusions
This chapter highlighted the mouse tail model as a unique experimental tool for
investigations of interstitial convective solute transport. It is novel both in its approach as
well as its capabilities. By offering a simple experimental method for evaluating size
exclusion phenomena in vivo, it can be used to quickly and easily characterize differences
in interstitial transport between different types of molecules. This can be extremely useful
for evaluating resistances to protein transport, for example, or for optimizing drug delivery.
Furthermore, the coinjection of the solute with a standard reference molecule greatly
increases sensitivity by eliminating experimental differences between animals, injection
conditions, and flow characteristics particular to the needle placement and specific anatomy
of each mouse tail.
Analysis of the solute concentration profiles proved to be nontrivial. Several
theoretical models to describe bulk or observable transport behavior were considered, and
each were successful in phenomenologically describing at least one characteristic trait. Of
those considered, a convection-dispersion model was the most successful at distinguishing
transport characteristics of the experimental solute molecules.
We can conclude from the studies in this chapter that size exclusion plays a
dominant role in determining the behavior of interstitial convective transport of
macromolecules. The studies also suggest that the lymphatics pose little resistance to solute
uptake compared to that of the tissue. In other words, if a solute particle can move through
the interstitium, it can move even more easily into the lymphatics - this makes intuitive
sense because otherwise interstitial accumulation would occur and steady-state oncotic
pressure would not be attainable. Finally, it was shown that although size poses the major
barrier to transport, charge and configuration of the solute may also affect transport
behavior. Some representative molecules were used to make this point clear. It should be
emphasized that the experimental studies presented in this chapter were focused on
illustrating the development, utility, and sensitivity of the model.
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Chapter 7
Model Applications
7.1 Introduction
This chapter illustrates some applications in physiology, medicine, and biology of
the model and methods developed in Chapters 3-5. One of the most relevant and important
issues in interstitial-lymphatic mechanics is lymphedema. Therefore the first part of this
chapter describes the modification of the mouse tail model for lymphedema and a unique
surgical technique proposed to relieve certain types of lymphedema. It also reveals
physiological implications of such states and quantifies changes which occur in tissue fluid
balance at regular time intervals. This work was borne from a collaboration with two
surgeons, Drs. Bert Losken and Sumner Slavin of Beth Israel Deaconess Medical Center,
and a radiologist, Dr. Annick Van den Abbeele of the Dana-Farber Cancer Institute.
The second part of this chapter describes the application of the model to characterize
a genetic rather than surgical modification. This involved a collaboration with Drs. Arja
Kaipainen and Kari Alitalo, molecular biologists from Helsinki, Finland. They had
discovered a gene responsible for lymphatic endothelial cell growth and developed a strain
of transgenic mice in which this gene was upregulated specifically in the skin. We
performed analyses on the tails of these mice according to the methods of Section 5.5 to
evaluate the effects of this condition on tissue fluid balance parameters. Therefore, net
macroscale effects (in vivo) could be correlated with microscopic observations of gene
expression and cell growth (ex vivo). What resulted were valuable insights into lymphatic
physiology (which were the first of its kind) and a foundation for integrative studies on
mechanotransduction mechanisms in lymphatic regulation of tissue fluid balance.
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7.2 Surgical models of lymphedema and tissue flap transfer
7.2.1 Background
Lymphedema is a disease characterized by abnormal collections of fluid and
proteins within the interstitial space. Although it can be congenital, lymphedema most
commonly occurs on a secondary basis following infection, trauma, malignancy, or
treatment for malignant disease with surgery, radiation therapy, or both (Mortimer 1997,
Pezner et al 1986, Ivens et al 1992, Kanter et al 1990). Treatment options for this
debilitating condition have included drug therapy, physical therapy, and surgical
approaches which have yielded limited success (Mortimer 1997, Campisi et al 1995,
Baumeister and Sivda 1990, Savage 1984, Huang et al 1985).
This study had two main goals. The first was to establish an animal model of
lymphedema both for its own sake as well as for the evaluation of a potential surgical
treatment for certain types of lymphedema, a tissue flap transfer. The second goal was to
then use this model to evaluate changes in tissue fluid balance parameters according to the
methods outlined in Chapter 5. The surgical treatment option was based on the idea to
transfer a small "flap" of tissue from a nearby region with its major artery and vein intact in
order to maintain original vascularization. This flap was then sewn into the edematous
tissue, offering an alternative route for fluid drainage. The hypothesis that lymphatic
continuity is restored in damaged or transplanted tissues was based on clinical observations
in patients who had undergone microsurgical reconstruction of post-traumatic deformities
(Smith et al 1987, Slavin et al 1997). In each instance, lymphatic continuity was either
restored by the addition of healthy tissues or occurred spontaneously in the absence of
surgical lymphatic repair.
Acute lymphedema was produced by ligation of the preischial lymphatics (see
Figure 3-3), followed by flap reconstruction in the experimental group. In addition to tail
circumference measurements, lymphatic drainage was evaluated by lymphoscintigraphy,
and local uptake and flow patterns were observed by fluorescence microlymphangiography
(see Chapter 3 for details)
7.2.2 Methods
Experimental groups
This study used 29 female nude mice that weighed between 20-30 g. All surgical
procedures were performed inside a pathogen-free colony. Anesthesia was achieved with
subcutaneous injections of ketamine (87 mg/kg) and xylazine (13 mg/kg). Animals were
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closely monitored post-operatively and received analgesia (butorphanol 3.3 mg/kg SQ q 4-
6) when necessary.
The mice were divided into five groups. Group B 1 consisted of 6 mice with tail
lymphatic ligation only. Group B2 also consisted of 6 mice which underwent ligation and
myocutaneous flap transfer. B3-B5 were control groups: B3 was a group of 10 normal
animals, B4 consisted of 5 mice with lymphatic tail ligation plus sham myocutaneous flap,
and B5 was made up of 2 mice with sham myocutaneous flap only . The sham flap was
similar to the experimental tissue flap except that it was replaced in situ on the abdomen and
sutured to its original site rather than transpose the flap to the tail. These groups served as
surgical controls.
In all groups, tail diameters were measured with a caliper at a consistent position on
the tail base, which corresponded to approximately 1 mm distal to the ligation in the
experimental groups. Interstitial fluid pressure (IFP) was measured with a wick-in-needle
method, which is described in Section 3.5.1.
Lymphatic ligation
To identify the deeper lymphatic vessels which led to the ischial nodes, 5-10 pl of
5% blue dextran 2M (Sigma, St. Louis) in physiological saline (0.9%) was injected into the
tip of the tail. The operative site at the base of the tail was then cleansed with 70% ethanol
and povidone/iodine, and a circumferential incision was made through the dermis to sever
the superficial lymphatic network. The two deep lymphatic vessels located in the lateral
aspects of the tail were divided and cauterized under loupe magnification (2.5 x). Finally,
cauterization was applied to the edges of the circumferential wound which resulted in a gap
of approximately 1 mm between the skin edges followed by secondary healing at the site of
ligation.
Myocutaneous tissue flap transfer
For the experimental group (B2), the tail lymphatics were ligated as described
above. A 10-15 mm skin incision was made overlying the left rectus abdominis muscle
using dissecting scissors. The skin was secured to the rectus muscle at three separate
locations to prevent disruption of the myocutaneous perforating vessels. The rectus muscle
was incised and the resulting flap was then raised as a unit. The inferior epigastric vessels
were identified, defining the pedicle of the flap. Hemostasis was achieved with
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cauterization. The abdominal muscles were reapproximated with 4-0 chromic catgut suture
(Ethicon). The abdominal skin incision was extended inferiorly to the tail reaching the
circumferential wound. Next, the flap was rotated medially 1800 on its pedicle and sutured
with 6-0 nylon to the distal edge of the prepared recipient site (just distal to the
circumferential wound). The remaining skin edges were reapproximated with interrupted 6-
0 nylon sutures. This procedure is depicted below in Figure 7-1.
A B
Figure 7-1. Myocutaneous flap design. (A), (B) The flap is inferiorly based, incorporating
the inferior deep epigastric artery. (C) The flap has been transposed inferiorly onto the tail
proximal to the site of lymphatic ligation
Lymphoscintigraphy (LS)
Each lymphoscintigraphy was performed in the Division of Oncologic Nuclear
Medicine of the Dana-Farber Cancer Institute in Boston. Tc-99m-An-sulfur colloid (SC,
CIS-US, INC., Bedford, MA) was prepared according to the manufacturer's instructions.
The solution was allowed to cool for 15 min and the contents of the vial were then filtered
through a Millipore Millex-GS 0.22 mm filter unit. The final preparation was diluted to a
concentration of 10 mCi/ml. Quality controls on the filtered product were greater than 95%
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bound. This filtered SC preparation is routinely used for lymphoscintigraphic studies in
patients. Tc-99m-filtered SC was injected intradermally 1 cm from the tip of the tail of
anesthetized mice at a dose of 500 gci (18.5 MBq) in a volume of 50 l using a 26- or 30-
gauge needle.
Imaging of mice was performed on a weekly basis starting the first week post-
surgery and up to 13 weeks. Sequential anterior and lateral whole body views (15
min/image) were obtained starting 5 min post-injection up to 3 hours post-injection using a
large field of view gamma camera Siemens Body scanner, Siemens MultiSpect 2 (Hoffman
Estates, Illinois) or Picker SX-300 (Picker International Inc., Pittsburgh, PA) equipped
with an all purpose low energy parallel-hole collimator with a 20% window centered over
the 140 keV photopeak. The matrix size was 256 x 256 and a magnification of 1.2-2.6 was
used. Animals were kept anesthetized for the duration of the imaging sessions (up to two
hours).
Fluorescence microlymphangiography (FM)
FM was performed on the mice once per week post-operatively. The two main
goals of this were to collect qualitative images of lymphatic staining and filling patterns and
to evaluate quantitatively the tissue fluid balance parameters. A solution of 2% FITC-Dx
2M was continuously infused intradermally at a constant pressure of 45 cm H20 (33 mm
Hg) as described in Chapter 3. After 30 minutes, these fluorescent images of the superficial
capillary network were recorded and photographed, with special attention to the extent of
the stained network as well as patterns near the ligated region and across the flap. Then, at
30-minute intervals, the infusion pressure was increased by 5 cm water for a total of four
infusion pressures (45, 50, 55, and 60 cm H20). During each 30-minute interval, the
length of the interstitial fluorescence deposit was monitored and the infusion flow rate
recorded so that the parameters K and 3 (overall effective hydraulic conductivity and net
lymphatic conductance) could be estimated according to the methods outlined in Section
5.5.
After 14 weeks, three mice each from groups B l-B3 were sacrificed and the ischial
lymph nodes were dissected, compressed between a glass slide and cover slip, and
examined for fluorescence.
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7.2.3 Results
Establishment of lymphedema and reduced swelling with flap transfers
All animals survived the procedures and healed within two weeks. The flaps
appeared to have excellent blood supply. Each flap healed to the tail dermal tissues without
separation of the wound edges, regardless of whether the flap was actually transposed
distally to the tail or replaced in situ (groups B2 and B4). No partial or complete necrosis
was observed in any flap, nor was there any evidence of wound infection.
Figure 7-2 (right) shows the persistence of edema in the ligation group (B 1) with
tail diameter increases of roughly 20-50% seen throughout the 14-week period in this
group as well as the ligation control groups (B4 and B5). Considering the anatomy of the
tail, where approximately 35% of the cross-sectional area consists of bone, this
corresponds to 60-200% increases in tissue volume. Lymphedema was sustained in groups
B 1 and B4 for over 60 days in all animals and over 100 days in those which were not
sacrificed for lymph node dissection. In the animals undergoing flap transfer following
ligation (B2), only slight swelling near the ligation was evident and lymphedema was not
seen in any of these animals (Figure 7-2 center). Tail diameters are shown in Figure 7-3.
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Figure 7-2. Left: sham flap control without ligation (B5). Center: flap with lymphatic
ligation (B2). Right: ligation-only animal (B 1).
136
6.5
6 --0- Ligation only
Flap+ligation
5.5
5
r 4.5
4
3.5 I I
0 20 40 60 80 100 120
Time (days)
Figure 7-3. Average tail diameter increases for the experimental groups. Solid circles,
experimental group (B2); open circles, ligation and sham flap groups (B1 and B4);
triangles. Normal groups (no change) not shown.
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Lymphatic continuity demonstrated by LS
LS in normal animals (B3) confirmed the lymphatic anatomy described previously
(Engeset and Tjtitta 1960). A typical mouse tail lymphoscintigram is shown in Figure 7-4a.
All animals showed one or both of the major lymphatic vessels in the tail connecting with
one or both lymph nodes located laterally at the base of the tail (the ischial nodes). The
lymphatic flow beyond the ischial node(s) resulted in the visualization of the lumbar and/or
the renal node in most animals. The pattern of lymphatic vessels and nodal groups seen in
the normal animals was also visualized in the animals who underwent a sham flap transfer
without ligation (B5, shown in Figure 7-4b). Hepatic activity was always seen and is
expected when communication between the lymphatic and venous systems is preserved.
Activity was seen in the bladder, kidneys, liver, and thyroid in less than ten percent of
animals; this may have been related to the presence of a small amount of free Tc-99m-
pertechnetate in the final preparation as well as to some systemic distribution secondary to
local superficial disruption of capillary vessels at the site of injection or direct
communication with the thoracic duct.
Ligation control animals (Figure 7-4c) showed diffuse uptake within the entire
surface of their enlarged tail equivalent to the "cutaneous flare" or dermal back flow seen in
patients with lymphedema (Mandell et al 1993, McNeill et al 1989). In addition, no lymph
node groups were visualized. The bladder, kidneys and liver were visualized as in the
experimental and control groups, again most likely because of partial systemic distribution
of free Tc-99m-pertechnetate. However, the pattern of tracer distribution in this group
looked very different from the normal animals who showed no diffuse cutaneous uptake
and who always demonstrated at least one lymph node group (B3, Figure 7-4a).
The experimental group that underwent ligation followed by flap transfer (B2,
Figure 7-4d) showed linear uptake along the route of the lymphatic vessels in the tail
without generalized diffuse uptake as seen in the group with ligation only. Although no
lymph node groups were seen during the first week post-operative, they were visualized in
the ischial, lumbar, and/or renal regions as early as 2 to 3 weeks post-operative. At that
time, lymphoscintigraphy in these animals was virtually indistinguishable from that in
normal animals suggesting that reconnection or restoration of lymphatic continuity had
taken place within 2-3 weeks following flap transfer, as has been observed previously in
patients (Slavin et al 1997).
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Figure 7-4. Lymphatic vessels and nodal groups in mice as evaluated by LS. The
lymphatics and nodes are visualized in the normal (B3, A) and sham flap animals (B5, B).
Note the diffuse uptake and the absence of nodal groups in the group of mice that
underwent ligation only (B 1, C). Restoration of lymphatic vessels and nodal group
visualization is seen in the group of animals that underwent flap transfer following ligation
(B2, D). Abbreviations: A = normal control (B3), B = sham flap without ligation (B5), C =
ligation only (B 1), D = ligation and flap transfer (B2); T = lymphatic vessels in the tail,
I.N. = ischial node; L.N. = lumbar node; R.N. = renal node, L = liver, Bl = bladder.
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Flow patterns visualized by FM
Lymphatic flow characteristics, observed weekly with fluorescence
microlymphangiography, developed distinctive patterns in each group after 2-3 weeks.
Representative photographs from each group of the proximal one-third of the tail, taken 3
weeks post-operatively, are shown in Figure 7-5. The top image shows the lymphatic
capillary network of a normal mouse tail (B3). Here, the fluorescent solution is taken up by
the lymphatics in the tail tip and stains most of the superficial network. However, its
intensity is decreased as it travels proximally and drains to the deeper vessels; the
superficial network is barely visible in the most proximal third to fourth part of the tail and
only the two deeper vessels along the sides of the tail can be detected. The center image
shows the lymphatic capillary network of an edematous tail from group B 1 (ligation only).
The network is stained in a random manner, indicating backflow from the deeper
lymphatics, and near the ligation the fluorescent dye has leaked out from the lymphatics
into the swollen tissue. This corresponds to the "cutaneous flare" often seen in patients
with lymphedema and in the lymphoscintigrams of this group. This flow pattern was also
seen in animals with ligated lymphatics and sham flap (B4).
A representative mouse tail from the experimental group, B2, is shown at the
bottom of Figure 7-5. Here, the entire network is stained along the entire length of the tail.
However, no lymphatic "leakage" into the tissue was detected, and fluorescent dye could
be seen in the flap tissue close to the site of ligation. This indicated evidence of restored
lymphatic continuity from the superficial lymphatic structures of the tail into those of the
flap.
Finally, the lymph nodes from 3 mice in each group, sacrificed at the end of the
fourteen week observation period, also verified that lymphatic reconnection had been
achieved with the flap transfer. All the mice in groups B2 and B3 showed fluorescence in at
least one node, while none of those in groups B 1 or B4 contained fluorescent material,
maintaining that total lymphatic obstruction had been achieved and sustained in these
animals.
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Figure 7-5. Fluorescent images of the cutaneous lymphatic network near the base of the tail
following an interstitial infusion of FITC-Dextran 2M at the tail tip. Top: A representative
image from the control group (normal mouse, B3). Fluorescent dye from the superficial
network is seen draining into the deeper vessels along the sides such that only 3/4 of the tail
network can be seen. Middle: representative image from the ligation group (B 1). Note the
discontinuity of network staining and leakage into the interstitium. Bottom: Lymphatic
continuity is restored in the edematous tail following surgical flap transfer (B2). This
"reconnection" is seen in the newly grafted tissue from the ligation site.
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Evaluation of tissue fluid balance parameters
From each group, the parameters K and 3 - representing the bulk-effective
hydraulic conductivity and lymphatic conductance respectively - could be estimated
according to the methods of Section 5.5. Specifically, the product K./ was found from
comparing infusion pressure vs. infusion flow rate (Equation 5.21), and the ratio /K from
the relationship between characteristic length and infusion pressure (Equation 5.32).
Typical data for each are shown in Figures 7-6 and 7-7, which reveal the extent of
differences seen between the lymphedema, normal, and flap groups.
The parameters IFP, IFV, K, and P for all experimental groups are presented in
Figure 7-8 as normalized quantities, relative to the normal controls. Their absolute values
are tabulated in Table 7.1.
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Figure 7-6. Representative data for infusion pressure vs. infusion flow rate for each
experimental group. The slope is defined in Equation 5.21.
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Figure 7-7. Representative data for infusion pressure vs. length of interstitial "front" for
each experimental group. The slope is defined by Equation 5.32.
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7.2.4 Discussion
A new model for lymphedema was developed using the mouse tail model as well as
a surgical model for tissue flap transfer. These models were evaluated for changes in tissue
fluid balance and lymphatic function over time using two techniques, lymphoscintigraphy
(LS) and fluorescence microlymphangiography (FM). The mouse tail models were ideal in
their experimental simplicity, reproducibility, and straightforward analysis. By
documenting changes that occur following a flap transfer and/or lymphatic ligation, we
have introduced and characterized reliable animal models which can be used to explore the
potentials of surgical as well as non-surgical treatments of lymphedema and improve our
understanding of lymphatic function.
The lymphatic capillary staining patterns shown in Figure 7-5 can be discussed
using an analogy to electrical resistances. In the tail skin, a superficial network of lymphatic
capillaries drains to two deeper lateral vessels which in turn drain into the ischial nodes as
shown by LS. In the control (normal) mouse, FM revealed patterns of lymph flow which
suggested that the lymphatic capillaries posed a somewhat greater resistance to flow than
the deeper vessels to the extent that roughly 75% of the superficial network was visible.
Thus, relative resistances to flow can be qualitatively evaluated - the smaller the extent of
stained network, the greater the ratio of resistances between the capillary network and the
deeper vessels. In the ligated, edematous tails, almost the entire network was stained with
backflow from deeper lymphatics evident by a randomness or discontinuity of staining.
This suggested that although the superficial network still presented a greater resistance to
lymph flow than the deeper vessels, the blockage of the deeper vessels left the superficial
network as the only pathway for lymph flow. Furthermore, the presence of dye "leakage"
near the ligation site (also seen with LS as a cutaneous flare) implied that the deeper
lymphatics remained at least partially functional after ligation and that the forces for lymph
flow rely particularly on local intrinsic pumping mechanisms (as opposed to systemic
driving forces such as respiration). This finding is consistent with previous work
(Bollinger 1993), where FM was performed in human skin to show that the extent of
network staining increased significantly in edema patients (also suggesting an increase in
relative resistance of the deeper lymphatics in edematous regions). Other studies have also
reported dermal backflow or cutaneous flare in patients with lymphedema (Mandell et al
1993, McNeill et al 1989).
In the ligation with flap transfer group (B2), lymph flow was "restored" after 10-14
days as suggested by LS and FM with results similar to the control groups. FM showed the
absence of edema, the presence of fluorescent material in the flap tissue, and little or no
evidence of backflow or leakage near the ligation. Furthermore, LS demonstrated
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continuity with major lymphatic vessels and lymph node groups in the experimental (flap)
animals after 14 days.
7.2.5 Physiological implications
Aside from presenting valuable experimental tools for the study of various states of
tissue fluid balance, these studies provided novel insight into the pathophysiology of
lymphedema which were supported or suggested by previous studies (Aukland and Reed
1993, Hogan and Unthank 1986, Schmid-Sch6nbein 1990, Leak 1976, Ryan 1989,
Castenholz et al 1991a, Negrini et al 1996, Aarli and Aukland 1991, Zaugg-Vesti et al
1993).
First of all, IFP was seen to decline rapidly within days of lymphatic ligation. This
is shown in Figure 7-8(a) and correlated with severe increases in interstitial fluid volume
(IFV), measured by increases in tail diameter and shown in Figure 7-3. This indicates a
loss in tissue elasticity (or increase in compliance), which has also been shown to
accompany various types of edema by other investigations. For example, Aarli and
Aukland (1991) induced chronic edema in the rat tail by venous stasis rather than lymphatic
ligation and measured a compliance of 0.93 ml / 100 g tissue / mm Hg (0.93% per mm
Hg). This was compared to their earlier study of compliance during acute edema (Aukland
and Wiig 1984), which was 0.19% or nearly 5 times less than that during long-term edema
(several days). This large increase in compliance apparently takes place over a matter of
days, which is also the approximate timescale observed for ECM reorganization (Aukland
and Reed 1993). Supporting this is the observation that small fragments of hyaluronic acid,
a building block of the proteoglycans which help to "glue" tissue fibers together and
provide elastic resistance to deformation (Aukland and Reed 1993, Levick 1987), are found
in much greater free concentration in edematous tissue than that found in normal tissue
(Negrini et al 1996). This suggests an alteration of ECM and a possible proteolytic
response of the tissue cells (i.e. keratinocytes or fibroblasts) to swelling, which would
manifest a decrease in elasticity. Therefore, our in vivo observations of greatly reduced
elasticity support this body of literature and also allow day-to-day changes to be quantified.
Next, the decrease in elasticity is also supported by the increase in hydraulic
conductivity (K) as shown in Figure 7-8(b). As explained in Chapter 5, the important
dependence of hydraulic conductivity on swelling has been observed since Guyton's
classical studies of tissue compliance (Guyton et al 1966). In normal mice, the same
infusion pressure yielded an estimate of K which was an order of magnitude lower than
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that in the edematous tails. The fact that K was seen to increase with time contributes to the
idea of a compromised ECM.
Finally, the fact that fl also increased with edema indicates that the anchoring
filaments, which connect the endothelium of the initial lymphatics with the ECM to facilitate
lymphatic drainage, remain intact despite the loss of normal ECM structure. It also signifies
the relative importance of local vs. systemic drainage mechanisms. As described in Chapter
3, local swelling facilitates lymphatic drainage by exerting tension on the anchoring
filaments which in turn "open up" the otherwise floppy or collapsed initial lymphatic
vessels. This lymph must then move to the deeper lymphatics and eventually drain
systemically. Lymph is seen to form despite the downstream ligation of the deeper vessels,
i.e. the removal of systemic forces from local ones. Therefore, the increase in effective
lymphatic conductance reveals the local capacity to form lymph, and it also highlights the
importance of the anchoring filaments in local lymph formation.
7.2.6 Clinical implications
The absence of a clinically effective treatment for chronic lymphedema reflects a
need for an improved understanding of lymphatic function, including lymphatic
regeneration and repair. Previous observations in patients undergoing microvascular-free
flap reconstruction have demonstrated spontaneous return of lymphatic flow through the
transferred tissues and into the host lymphatics as rapidly as thirteen days post-operatively
(Slavin et al 1997). The present study was initiated by clinical observations of improved
lymphatic drainage in human subjects who had flap tissues bearing normal lymphatic
networks transferred to areas of abnormal lymph flow. In this study, identification and
ligation of the two major lymphatic vessels in the mouse tail provided prompt and
consistent swelling in each animal. Control groups undergoing either ligation with or
without a sham flap (B1 and B4) developed edema but showed no improvement as
determined by tail diameter and volume measurements or assessed by LS and FM.
Transfer of a rectus abdominus myocutaneous flap, vascularized by the deep
inferior epigastric artery, created a viable bridge between the obstructed lymphatic channels
of a ligated tail and the healthy lymphatic network of the cutaneous and subcutaneous
tissues of the flap. The excellent vascularity of the myocutaneous flap promoted wound
healing in the area of the tail as well as restoration of lymphatic flow at the junction of flap
and severed tail lymphatics. Previously interrupted lymphatic flow showed improvement
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over a fourteen day period, culminating in LS and FM evidence of lymphatic transport
across the experimentally created obstruction with continuation to proximal nodes.
A precise timing of the process of reconnection - approximately two weeks -
suggests that lymphatic growth and repair can occur in an area of abnormal lymphatic
function. The importation of healthy lymphatic collectors, as carried by the rectus flap, acts
to promote drainage without the risk of donor-site lymphedema. Furthermore, unlike earlier
failures in canine models when microvascular anastomoses were performed, late
thrombosis was not observed, attesting to the stability of the new pathways.
This study should serve as a stepping stone for the identification of humoral factors
affecting afferent and efferent lymphatic continuity within the myocutaneous flap model. If
lymphatic pathways can reconnect following surgical division, this principle might be
useful to many patients suffering from chronic lymphedema.
7.3 Lymphatic hyperplasia'
The mouse tail model was also utilized for an investigation of the molecular basis of
lymphatic growth and development. The growth factor VEGF-C (vascular endothelial
growth factor C) and its receptor VEGFR-3 (vascular endothelial growth factor receptor 3)
were found to be specifically associated with the lymphatic endothelia (Kaipainen et al
1995, Kukk et al 1996). To study the in vivo effects of VEGF-C, three transgenic mouse
lines were created which expressed VEGF-C under a keratin promoter. Overproduction of
VEGF-C in skin keratinocytes led to the upregulation of its receptor VEGFR-3 in lymphatic
endothelia. As a result the skin lymphatic endothelial cells proliferated as shown in vitro by
incorporation of 5-bromo-2-deoxyuridine (BrdU), followed by staining with anti-BrdU
antibody. This stained cells which were in the S-phase of DNA synthesis and thus
indicated proliferation. Histology revealed that the vessels were dilated and on average
contained more cells per cross-section than usual. The in vivo studies developed for the
mouse tail model in Section 5.5 were then utilized to evaluate differences in lymphatic
conductance and staining patterns of the lymphatic .capillary network, thus providing
insight into the functional implications of this growth factor as well as a basis for further
investigations.
'This work is partially presented in Jeltsch et al 1997.
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Fluorescence microlymphangiography of the superficial capillary network in the
transgenic mouse tail skin verified the dilation of the lymphatic vessels and are shown in
Figure 7-9. This also confirmed the BrdU evidence of proliferation. However, while it
verified that the upregulation of VEGF-C induced proliferation of lymphatic endothelial
cells, it also suggested that this growth factor does not play a primary role in
lymphangiogenesis. That is, no new or sprouting lymphatic vessels were seen and the
lymphatic capillary density remained the same as that in the normal mouse.
Figure 7-9. Fluorescent microlymphangiography images of the superficial capillary
network of normal and transgenic mouse tail skin. Left: control mouse, where the average
diameter of a lymphatic vessel is 68 ± 22 pm and the distance across a hexagonal unit
(center -to-center of opposite vessels) is 490 + 60 pm. Right: VEGF-C upregulated mouse,
where the average vessel diameter is 142 ± 26 pm and the hexagonal mesh unit size is
approximately the same, 510 + 60 p.m.
Aside from qualitative observations, the tissue fluid balance parameters could also
be estimated with the methods outlined in Section 5.5. Hydraulic conductivity (K) was not
significantly different between the two mouse types, but there was nearly a threefold
difference in local lymphatic conductance (f). While the normal or control mice had a mean
value of 2.2 ± 0.6 x 10-5 s-'.mmHg -' (n=5), the transgenics showed a mean value of 8 ± 1
x 10-6 s-1 -mmHg-' (n=4).
149
N FGF-C'CONTROL
This was somewhat surprising but contributed valuable insight into lymphatic
physiology. It seems paradoxical that initial lymphatic vessels with a larger lumen would be
less effective at draining fluid. However, the image of the anchoring filaments (Figure 2-2)
is a reminder of the importance of interstitial-lymphatic communication in lymph formation.
The initial lymphatic vessels have no smooth muscle and are typically non-cylindrical and
often twisted or collapsed. The elastic fibers sense slight stresses in the interstitium which
facilitate lymph formation by pulling the vessel open and increasing the translymphatic
pressure difference, which is the driving force for lymph formation. This is consistent with
observations that IFV rather than IFP most clearly influences lymphatic drainage (Hogan
and Unthank 1986, Aarli et al 1990). If the vessels were larger but still twisted and partially
collapsed, then the same interstitial stresses would have a lesser effect on increasing the
intraluminal volume of the lymphatic vessel. In this way, larger initial vessels are less
effective at draining lymph than smaller ones. This effect has also been seen in tumor
vessels lacking smooth muscle cells (Jain 1988).
Therefore the tail model was useful for evaluating macroscopic changes due to
alterations in molecular control. Not only could we confirm histological data with
macroscale in vivo measurements of associated changes in tissue fluid balance parameters,
but along with Section 7.2, these studies also yielded fruitful information about the
importance of interstitial-lymphatic communication and its role in the pathophysiology of
lymphedema. Currently, these two studies are being combined and extended to delineate
molecular changes associated with lymphedema and tissue flap transfer. While the work
presented in this chapter evaluated macroscale consequences of molecular regulation,
current and future work examines molecular responses to changes in the macroscopic
environment (i.e. swelling and tissue transfer).
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Chapter 8
Conclusions and future direction
The main contribution of this thesis is a framework for comprehensive
investigations of interstitial-lymphatic transport. First, an experimental model was designed
for observing and evaluating flow in lymphatic capillaries using the mouse tail. Then the
physiology of lymph formation was explored, expanding the technical potential of the
model and constructing a theoretical foundation simultaneously. This parallel development
was necessary for optimizing relevance in the theoretical model and pertinence in the
experimental design. The experimental / theoretical model is further expanded to include
solute transport within the interstitial-lymphatic continuum.
The utility of the model was evaluated by its application to critical issues in
lymphatic function. Lymphedema and hyperplasia of lymphatic vessels are both related to
interstitial-lymphatic mechanics, and interstitial-lymphatic communication is critical in the
healing of wounds and tissue grafts. Physiological, pathological, and biological aspects of
lymphedema, hyperplasia, and tissue grafting were combined with the mechanical studies
that the mouse tail model could provide to yield valuable and comprehensive insight into
these problems.
The importance of this work can be summarized in the value of the model as a
theoretical and experimental tool along with the physiological implications of the applied
studies. The model was used to elucidate certain mechanical aspects of tissue fluid balance
as well as convective interstitial solute transport. As a result, it could be used to estimate the
hydraulic conductivity (K), elasticity (2M+A), and overall lymphatic conductance (f) of
skin in vivo. This is the first such in vivo tool. Solute transport was analyzed as a
convective-dispersive phenomenon, employing a drainage term to represent lymphatic
uptake. This approach was motivated by the chromatography-like concentration profiles
observed within the mouse tail skin. Once again, it was the first such model in which solute
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transport parameters (excluded volume fraction, dispersivity, and the lymphatic reflection
coefficient) could be estimated in vivo.
Applying the model to physiologically relevant problems has led to important
observations from the standpoint of interstitial-lymphatic biology. For example, edema was
found to be associated with a local increase in K and P, and caused a local decrease in IFP.
The latter suggested a loss of tissue elasticity, and although K is known to increase with
swelling (Guyton et al 1966, Bert and Fatt 1970, Levick 1987, Bert and Reed 1995), the
increase in P was not expected. This observation alone has two key implications: (1) local
forces dominate systemic forces in generating lymph formation and local lymph
propulsion, and (2) while the extracellular matrix (ECM) may be subjected to proteolysis
during sustained swelling, interstitial-lymphatic communication seems to be preserved (i.e.
the anchoring filaments remain intact and functional). In the tissue graft or flap transfer
model, lymphatic continuity was established between two different tissue types within two
weeks. Finally, the model was used on many levels simultaneously to show that solid
stress rather than IFP is the most important factor in lymphatic drainage, ECM
reorganization, and lymphatic cell gene expression.
This work establishes a unique framework for novel studies of interstitial-lymphatic
transport phenomena. Because it allows in situ examination of interstitial-lymphatic
mechanics and transport, it is an ideal tool for multi-scale investigations. The feasibility of
such a comprehensive model arises from the rapidly expanding field of molecular biology
and its emergence as a quantitative science. The scope of Chemical Engineering has been
expanding and changing over the past few decades to incorporate biology and physiology
as applications. As a result, its tools and approaches can be used to further our fundamental
understanding of biological and physiological systems as well as to translate current
knowledge into the development of biotechnology. The work presented in this thesis is an
example of such a multidisciplinary development which can both give and take from basic
science. In this case, fundamental principles of mechanics and transport were applied to a
physiological system, allowing for parallel development of experimental and theoretical
techniques, to produce a quantitative and relevant model. Advances in other fields (biology
and medicine) were incorporated into this model leading to a comprehensive tool. Such a
tool can be used both to further our understanding of physiological issues (i.e. tissue fluid
balance, edema, and lymphangiogenesis) as well as to explore and develop
biotechnological applications.
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One such application is the use of the lymphatic route for drug delivery. Because
the lymphatic capillaries have a markedly higher permeability than those of the blood,
particles of up to 500 nm can be selectively taken up from the interstitial space. Lymphatic
flow rates are 1-2 orders of magnitude less than that of blood, yielding long residence times
and minimal shear stress. Along with lymph node detention, these features are ideal for
specific targeting of lymph nodes. Delivery applications include contrast agents for lymph
node imaging (used for detection of tumor metastases), drugs which affect the immune
response by activating white blood cells against a particular antigen (immunomodulators,
currently investigated for HIV and cancer therapy), and some chemotherapeutics for the
treatment of lymph node metastases (Torchilin 1996, Charman et al 1992). In the case of
immunomodulators, systemic delivery trials have been unsuccessful due to liver
degradation and ineffective targeting; both may be avoided by lymphatic delivery. Also,
since the major problems with chemotherapy are the side effects resulting from systemic
distribution, the potential of specific targeting to lymph node metastases carries important
therapeutic implications. The model developed in this thesis is ideal for combining in vivo
studies of lymphatic transport with theoretical modeling of interstitial-lymphatic convection
and distribution, binding, and phagocytosis kinetics to explore the lymphatic delivery
route.
A second direction for this model is in the further exploration of mechanoregulation
of lymphatic growth and development. This work is currently being carried out as an
extension to the work presented in Chapter 7 in collaboration with Drs. Arja Kaipainen and
Judah Folkman of Children's Hospital in Boston. Since the lymphatic capillaries are
intrinsically and mechanically coupled to the ECM, their function not only depends on
tissue pressure and systemic lymphatic clearance but perhaps even more importantly on the
geometry and structure of the capillary network and surrounding ECM assembly.
Furthermore, the lymphatic endothelial cells may respond specifically to sustained local
mechanical forces by proliferation or apoptosis; enlarged and nonfunctional vessels are
often associated with various forms of lymphedema and cancers of the lymphatic system
(Mortimer 1997, Leu and Lie 1995). In fact, mechanotransduction mechanisms of
lymphatic development and disorders are completely unexplored. The work developed in
this thesis is an ideal foundation from which to bring together interstitial-lymphatic
transport mechanics at the macroscopic level with response and regulation at the molecular
level so that lymphatic regulation can be described quantitatively and comprehensively.
Finally, the role of the lymphatics in tumor growth and metastasis is another avenue
for future exploration. The lymphatics are the major route for dissemination of many soft
tissue tumors, such as breast and colon carcinomas, and the interaction between the
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growing tumor and the surrounding extracellular matrix is a critical factor in the prognosis
of such cancers (Lochter and Bissel 1995, Carr et al 1989). Furthermore, tumors are
typically devoid of functional lymphatic vessels. The unique qualitative and quantitative
features of the mouse tail model provide an ideal tool for studies of tumor-lymphatic
interactions. These features include the visibility of stained lymphatic vessels, the potential
to track labeled cells within the superficial lymphatic capillary network, the variety of
characterization techniques for lymphatic uptake, interstitial fluid balance, and flow within
the lymphatic capillaries.
Our overall understanding of lymphatic physiology and biology has lagged behind
that of the blood circulation. Thus, there exists many unanswered questions and a frontier
for exploration. The work developed throughout this thesis constitutes a unique foundation
for investigations of lymphatic function. These examples are just a few of the many
interesting future directions which arose from this work.
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Appendix A
Nomenclature
AC tissue cross-sectional area for fluid flow Ch. 5
A convective dispersion parameter (Dc = A-v) Ch. 6
C total tissue concentration Ch. 6
Cinf solute concentration of the infusate Ch. 6
D* effective dispersivity [mm 2/s] Ch. 6
D convective dispersivity [mm2/s] Ch. 6
D' molecular diffusivity [mm2/s] Ch. 6
e dilatation of solid phase of the interstitium Ch. 5
H bulk elastic modulus (2p+,) [mmHg] Ch. 5
J, net volumetric lymphatic fluid drainage [ml/g tissue/s] Ch.5
K hydraulic conductivity [mm 2 s' mm Hg-'] Ch. 5-7
K* effective pressure diffusivity (=K(2+,)) [mm2/s] Ch. 5
L average permeability of lymphatic capillary [mm/(s-mm Hg)] Ch. 5
n adsorbed solute concentration [moles per volume solid] Ch. 6
P interstitial fluid pressure (IFP) [mm Hg] Ch. 5-7
P* pressure above baseline; P-Po [mm Hg] Ch. 5-7
Pb Baseline IFP [mm Hg] Ch. 5-7
Pi interstitial fluid pressure (IFP or P) [mm Hg] Ch. 5
P, intralymphatic (local) pressure [mm Hg] Ch. 5
Po infusion pressure [mm Hg] Ch. 5-7
Po applied pressure above baseline (P, - Pb) [mm Hg] Ch. 5-7
Q net flow rate of infusion [gl/s] Ch. 5-7
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Q steady-state flow rate of infusion [pl/s] Ch. 5-7
R, net systemic resistance to lymphatic drainage [s.mm Hg] Ch. 5
R, total lumped (series) resistance to lymphatic drainage [s-mm Hg] Ch. 5
R,, lymphatic uptake rate of solute [moles/g/s] Ch. 6
S/V surface area-to-volume ratio of lymphatic capillaries [mm1] Ch. 5
t dimensionless time Ch. 6
T mean residence time (MRT) Ch. 4-6
u solid displacement vector Ch. 5
W average solid displacement vector Ch. 5
Uo  mean solute velocity at x=O [mm/s] Ch. 6
U* mean solute velocity [mnm/s] Ch. 6
Vbulk bulk (average) fluid velocity (vbulk= E.Vore) Ch. 6
V bulk fluid velocity vector (if = e. V) Ch. 6
Vpore average pore fluid velocity Ch. 6
f average pore fluid velocity vector Ch. 5
dimensionless distance Ch. 6
a characteristic (SS) length of pressure and solute profiles [mm] Ch. 5-7
f lymphatic conductance [s' mm Hg-'] Ch. 5-7
E porosity or fluid volume fraction Ch. 5-6
_ Cauchy strain tensor Ch. 5
Available volume fraction (fluid + partitioning phases)
for molecule or particle p Ch. 6
y insaturable adsorption affinity; y=-ic(1-e) Ch. 6
K partition coefficient for solute transport Ch. 6
i. 2nd Lam6 constant Ch. 5
Y 1st Lam6 constant Ch. 5
V linear adsorption coefficient [s'] Ch. 6
pf fluid density fraction of tissue Ch. 5
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p, solid density fraction of tissue
aL lymphatic reflection coefficient
t total tissue stress tensor
0 normalized intensity
Tf characteristic time for fluid transport
T, characteristic time for pressure equilibrium
Ts  characteristic time for solute transport
5" solute drag coefficient
(2y+Al)bulk elastic modulus (H) [mm Hg]
BSA
ECM
FITC
FITC-Dx 3K
FITC-Dx 71K
FITC-Dx 2M
Flt4
FM
FRAP
IFP
IFV
LS
MRT
RITC
RITC-Dx 73K
RTD
TR-Dx 3K
VEGF
VEGF-C
VEGFR3
bovine serum albumin
extracellular matrix
Fluoroisothiocyanate
FITC-labeled dextran, mol. weight 3,000 Da
FITC-labeled dextran, mol. weight 71,000 Da
FITC-labeled dextran, mol. weight 2,000,000 Da
fms-like tyrosine kinase receptor 4 (also called VEGFR3)
fluorescence microlymphangiography
fluorescence recovery after photobleaching
interstitial fluid pressure
interstitial fluid volume
lymphoscintigraphy
mean residence time
rhodamine B isothiocyanate
RITC-labeled dextran, mol. weight 73,000 Da
residence time distribution
Texas Red-labeled dextran, mol. weight 3,000 Da.
vascular endothelial growth factor (aka vascular permeability factor (VPF))
vascular endothelial growth factor C
vascular endothelial growth factor receptor 3 (also called Flt4)
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Ch. 5
Ch. 6
Ch. 5
Ch. 4-6
Ch. 4-6
Ch. 5
Ch. 6
Ch. 6
Ch. 5
Appendix B
Experimental data: pressure propagation
Figures B-1 (a)-(e) below show transient pressure profiles of each experiment used in
Chapter 5. Unmarked lines show IFP as measured with a micropipette while the lines
marked with circles show the infusion pressure which was measured with a pressure
transducer in the infusion line.
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Figure B-1 (a). Transient pressure profile; experiment #1.
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Figure B-1 (b). Transient pressure profile; experiment #2.
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Figure B-1 (c). Transient pressure profile; experiment #3.
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Figure B-1 (d). Transient pressure profile; experiment #4.
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Figure B-1 (e). Transient pressure profile; experiment #5.
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Appendix C
Experimental data: solute co-injections
Three experiments were performed for each FITC-labeled molecule (anionic Dx 3K, Dx
71K, Dx 2M, and BSA). Each solution was coinjected with TR-Dx 3K (neutral). Thus,
each data set is given as a pair of graphs, with the experimental molecule on the left and
TR-Dx 3K on the right. Timepoints are indicated on the legend in minutes. Intensities (y-
axis) have been corrected for background readings. The first three sets (Figs. C.1 (a)-(c))
show data for anionic Dx 3K; Figs. C.2 (a)-(c) show data for Dx 71K; Figs. C.3 (a)-(c)
show data for Dx 2M, and finally, Figs. C.4 (a)-(c) show data for BSA.
0 0.5 1 1.5 2
Distance (mm)
0 0.5 1
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Figure C-l (a) Experiment #1: spatial profiles of anionic FITC-Dx 3K (left) coinjected with
TR-Dx 3K (right). Times (in minutes) are indicated in the legend.
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Figure C-1 (b) Experiment #2: spatial profiles of anionic FITC-Dx 3K (left) coinjected with
TR-Dx 3K (right).
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Figure C-1 (c) Experiment #3: spatial profiles of anionic FITC-Dx 3K (left) coinjected with
TR-Dx 3K (right).
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Figure C-2 (a) Experiment #4: spatial profiles of FITC-Dx 71K (left) coinjected with TR-
Dx 3K (right).
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Figure C-2 (b) Experiment #5: spatial profiles of FITC-Dx 71K (left) coinjected with TR-
Dx 3K (right).
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Figure C-2 (c) Experiment #6: spatial profiles of FITC-Dx 71K (left) coinjected with TR-
Dx 3K (right).
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Figure C-3 (a) Experiment #7: spatial profiles of FITC-Dx 2M (left) coinjected with TR-Dx
3K (right).
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Figure C-3 (b) Experiment #8: spatial profiles of FITC-Dx 2M (left) coinjected with TR-Dx
3K (right).
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Figure C-3 (c) Experiment #9: spatial profiles of FITC-Dx 2M (left) coinjected with TR-Dx
3K (right).
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Figure C-4 (c) Experiment #12: spatial profiles of FITC-BSA (left) coinjected with TR-Dx
3K (right).
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